References
References
Acevedo A, Garnick DW, Dunigan R, et al: Performance measures and racial/ethnic disparities in the treatment of substance use disorders. J Stud Alcohol Drugs 76(1):57–67, 2015
ACOG Committee on Practice Bulletins—Obstetrics: ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008: use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 111(4):1001–1020, 2008
Agency for Healthcare Research and Quality: Methods Guide for Effectiveness and Comparative Effectiveness Reviews (AHRQ Publ No 10[14]-EHC063-EF). Rockville, MD, Agency for Healthcare Research and Quality, 2014
Aggarwal NK, Lewis-Fernández R: An introduction to the Cultural Formulation Interview. Focus 13(4):426–431, 2015
Allen JG, Frueh BC, Ellis TE, et al: Integrating outcomes assessment and research into clinical care in inpatient adult psychiatric treatment. Bull Menninger Clin 73(4):259–295, 2009
Al-Rousan T, Rubenstein L, Sieleni B, et al: Inside the nation’s largest mental health institution: a prevalence study in a state prison system. BMC Public Health 17(1):342, 2017
Al-Shamali HF, Winkler O, Talarico F, et al: A systematic scoping review of dissociation in borderline personality disorder and implications for research and clinical practice: exploring the fog. Aust N Z J Psychiatry 56(10):1252–1264, 2022
American Academy of Pediatrics, American College of Obstetricians and Gynecologists: Guidelines for Perinatal Care, 8th Edition. Elk Grove Village, IL, American Academy of Pediatrics, 2017
American College of Correctional Physicians: Restricted Housing of Mentally Ill Inmates. Marion, MA, American College of Correctional Physicians, 2013. Available at: https://accpmed.org/restricted_housing_of _mentally.php. Accessed September 22, 2019.
American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice, Breastfeeding Expert Work Group: Committee Opinion No. 658: Optimizing support for breastfeeding as part of obstetric practice. Obstet Gynecol 127(2):e86–e92, 2016
American College of Obstetricians and Gynecologists: ACOG Committee Opinion No. 736: Optimizing postpartum care. Obstet Gynecol 131(5):e140–e150, 2018
American Educational Research Association, American Psychological Association, National Council for Measurement in Education (ed): Standards for Educational and Psychological Testing. Washington DC, American Educational Research Association, 2014
American Medical Association Code of Medical Ethics: Opinion 1.1.5.: Terminating a Patient-Physician Relationship. Chicago, IL, American Medical Association, 2023a. Available at: https://code-medical-ethics.ama-assn.org/ethics-opinions/terminating-patient-physician-relationship. Accessed February 1, 2023.
American Medical Association Code of Medical Ethics: Opinion 2.1.3.: Withholding Information From Patients. Chicago, IL, American Medical Association, 2023b. Available at: https://code-medical-ethics.ama-assn.org/ethics-opinions/withholding-information-patients. Accessed February 1, 2023.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC, American Psychiatric Association, 1994
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000
American Psychiatric Association: Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 158(10 Suppl):1–52, 2001
American Psychiatric Association: Position Statement on Treatment of Substance Use Disorders in the Criminal Justice System. Arlington, VA, American Psychiatric Association, 2007. Available at: https://www.psychiatry.org/File%20Library/About-APA/Organization-Documents-Policies/Policies/Position-2007-Substance-Abuse-Criminal-Justice.pdf. Accessed September 22, 2019.
American Psychiatric Association: Outpatient Services for the Mentally Ill Involved in the Criminal Justice System. Arlington, VA, American Psychiatric Association, 2009. Available at: https://www.psychiatry.org/File%20 Library/Psychiatrists/Directories/Library-and-Archive/task-force-reports/tfr2009_outpatient.pdf. Accessed September 27, 2019.
American Psychiatric Association: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition. Am J Psychiatry 167(10 Suppl):1–118, 2010
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Arlington, VA, American Psychiatric Association, 2013a
American Psychiatric Association: The Principles of Medical Ethics With Annotations Especially Applicable to Psychiatry, 2013 Edition. Arlington, VA, American Psychiatric Association, 2013b. Available at: https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/Ethics/principles-medical-ethics.pdf. Accessed April 28, 2023.
American Psychiatric Association: WHODAS 2.0 (World Health Organization Disability Assessment Schedule 2.0): 36-item version, self-administered, in Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Arlington, VA, American Psychiatric Association, 2013c, pp 747–748
American Psychiatric Association: Practice Guidelines for the Psychiatric Evaluation of Adults, 3rd Edition. Arlington, VA, American Psychiatric Association, 2016a
American Psychiatric Association: Psychiatric Services in Correctional Facilities, 3rd Edition. Arlington, VA, American Psychiatric Association, 2016b
American Psychiatric Association: Position Statement on Segregation of Prisoners With Mental Illness. Arlington, VA, American Psychiatric Association, 2017. Available at: https://www.psychiatry.org/File%20Library/About-APA/Organization-Documents-Policies/Policies/Position-2012-Prisoners-Segregation.pdf. Accessed September 22, 2019.
American Psychiatric Association: Position Statement on Solitary Confinement (Restricted Housing) of Juveniles. Washington, DC, American Psychiatric Association, 2018. Available at: https://www.psychiatry.org/File%20Library/About-APA/Organization-Documents-Policies/Policies/Position-2018-Solitary- Confinement-Restricted-Housing-of-Juveniles.pdf. Accessed October 3, 2019.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision. Washington, DC, American Psychiatric Association, 2022a
American Psychiatric Association: DSM-5-TR Online Assessment Measures. Washington, DC, American Psychiatric Association, 2022b. Available at: https://www.psychiatry.org/psychiatrists/practice/dsm/educational-resources/assessment-measures#section_16. Accessed August 28, 2023.
American Psychiatric Association: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, 4th Edition. Washington, DC, American Psychiatric Association, 2023
American Public Health Association: Solitary Confinement as a Public Health Issue. Washington, DC, American Public Health Association, 2013. Available at: https://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2014/07/14/13/30/solitary-confinement-as-a-public-health-issue. Accessed September 22, 2019.
Amianto F, Ferrero A, Pierò A, et al: Supervised team management, with or without structured psychotherapy, in heavy users of a mental health service with borderline personality disorder: a two-year follow-up preliminary randomized study. BMC Psychiatry 11:181, 2011
Anderson LJ, Nuckols TK, Coles C, et al: A systematic overview of systematic reviews evaluating medication adherence interventions. Am J Health Syst Pharm 77(2):138–147, 2020
Andión Ó, Ferrer M, Matali J, et al: Effectiveness of combined individual and group dialectical behavior therapy compared to only individual dialectical behavior therapy: a preliminary study. Psychotherapy (Chic) 49(2):241–250, 2012
Andreoli A, Burnand Y, Cochennec MF, et al: Disappointed love and suicide: a randomized controlled trial of “abandonment psychotherapy” among borderline patients. J Pers Disord 30(2):271–287, 2016
Andrews JC, Schünemann HJ, Oxman AD, et al: GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation’s direction and strength. J Clin Epidemiol 66(7):726–735, 2013
Ansell EB, Pinto A, Edelen MO, et al: The association of personality disorders with the prospective 7-year course of anxiety disorders. Psychol Med 41(5):1019–1028, 2011
Arntz A, van Genderen H: Schema Therapy for Borderline Personality Disorder, 2nd Edition. Hoboken, NJ, Wiley-Blackwell, 2021
Bach B, Tracy M: Clinical utility of the alternative model of personality disorders: a 10th year anniversary review. Personal Disord 13(4):369–379, 2022
Bachelor A: Clients’ and therapists’ views of the therapeutic alliance: similarities, differences and relationship to therapy outcome. Clin Psychol Psychother 20(2):118–135, 2013
Bahji A, Bach P, Danilewitz M, et al: Pharmacotherapies for adults with alcohol use disorders: a systematic review and network meta-analysis. J Addict Med 16(6):630–638, 2022
Baier AL, Kline AC, Feeny NC: Therapeutic alliance as a mediator of change: a systematic review and evaluation of research. Clin Psychol Rev 82:101921, 2020
Baillargeon J, Binswanger IA, Penn JV, et al: Psychiatric disorders and repeat incarcerations: the revolving prison door. Am J Psychiatry 166(1):103–109, 2009a
Baillargeon J, Penn JV, Thomas CR, et al: Psychiatric disorders and suicide in the nation’s largest state prison system. J Am Acad Psychiatry Law 37(2):188–193, 2009b
Baillargeon J, Hoge SK, Penn JV: Addressing the challenge of community reentry among released inmates with serious mental illness. Am J Community Psychol 46(3–4):361–375, 2010
Baker J, Beazley PI: Judging personality disorder: a systematic review of clinician attitudes and responses to borderline personality disorder. J Psychiatr Pract 28(4):275–293, 2022
Bales DL, Timman R, Andrea H, et al: Effectiveness of day hospital mentalization-based treatment for patients with severe borderline personality disorder: a matched control study. Clin Psychol Psychother 22(5):409–417, 2015
Balshem H, Helfand M, Schünemann HJ, et al: GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64(4):401–406, 2011
Barker E, Kõlves K, De Leo D: Management of suicidal and self-harming behaviors in prisons: systematic literature review of evidence-based activities. Arch Suicide Res 18(3):227–240, 2014
Barnhill JW: The psychiatric interview and mental status examination, in The American Psychiatric Publishing Textbook of Psychiatry, 6th Edition. Edited by Hales RE, Yudofsky SC, Roberts LW. Washington, DC, American Psychiatric Publishing, 2014, pp 3–30
Barnicot K, Crawford M: Dialectical behaviour therapy v. mentalisation-based therapy for borderline personality disorder. Psychol Med 49(12):2060–2068, 2019
Barnicot K, Priebe S: Post-traumatic stress disorder and the outcome of dialectical behaviour therapy for borderline personality disorder. Personal Ment Health 7(3):181–190, 2013
Barnicot K, Katsakou C, Marougka S, et al: Treatment completion in psychotherapy for borderline personality disorder: a systematic review and meta-analysis. Acta Psychiatr Scand 123(5):327–338, 2011
Barnicot K, Redknap C, Coath F, et al: Patient experiences of therapy for borderline personality disorder: commonalities and differences between dialectical behaviour therapy and mentalization-based therapy and relation to outcomes. Psychol Psychother 95(1):212–233, 2022
Barr KR, Townsend ML, Grenyer BFS: Using peer workers with lived experience to support the treatment of borderline personality disorder: a qualitative study of consumer, carer and clinician perspectives. Borderline Personal Disord Emot Dysregul 7:20, 2020
Barr KR, Townsend ML, Grenyet BFS: Peer support for consumers with borderline personality disorder: a qualitative study. Adv Ment Health 20(1):74–85, 2022
Barroilhet SA, Ghaemi SN: When and how to use lithium. Acta Psychiatr Scand 142(3):161–172, 2020
Bartak A, Andrea H, Spreeuwenberg MD, et al: Effectiveness of outpatient, day hospital, and inpatient psychotherapeutic treatment for patients with Cluster B personality disorders. Psychother Psychosom 80(1):28–38, 2011
Bartels N, Crotty T: A Systems Approach to Treatment: The Borderline Personality Disorder Skill Training Manual. Winfield, IL, EID Treatment Systems, Inc, 1992
Bateman AW, Fonagy P: Mentalization-based treatment of BPD. J Pers Disord 18(1):36–51, 2004
Bateman A, Fonagy P: Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry 166(12):1355–1364, 2009
Bateman A, Constantinou MP, Fonagy P, et al: Eight-year prospective follow-up of mentalization-based treatment versus structured clinical management for people with borderline personality disorder. Personal Disord 12(4):291–299, 2021
Beatson JA, Broadbear JH, Duncan C, et al: Avoiding misdiagnosis when auditory verbal hallucinations are present in borderline personality disorder. J Nerv Ment Dis 207(12):1048–1055, 2019
Bebbington P, Jakobowitz S, McKenzie N, et al: Assessing needs for psychiatric treatment in prisoners: 1. Prevalence of disorder. Soc Psychiatry Psychiatr Epidemiol 52(2):221–229, 2017
Beck E, Bo S, Jørgensen MS, et al: Mentalization-based treatment in groups for adolescents with borderline personality disorder: a randomized controlled trial. J Child Psychol Psychiatry 61(5):594–604, 2020
Bellino S, Zizza M, Rinaldi C, Bogetto F: Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy. Can J Psychiatry 51(7):453–460, 2006
Bellino S, Zizza M, Rinaldi C, Bogetto F: Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy. Can J Psychiatry 52(11):718–725, 2007
Bellino S, Rinaldi C, Bogetto F: Adaptation of interpersonal psychotherapy to borderline personality disorder: a comparison of combined therapy and single pharmacotherapy. Can J Psychiatry 55(2):74–81, 2010
Bender DS: The therapeutic alliance in the treatment of personality disorders. J Psychiatr Pract 11(2):73–87, 2005
Berg SH, Rørtveit K, Aase K: Suicidal patients’ experiences regarding their safety during psychiatric in-patient care: a systematic review of qualitative studies. BMC Health Serv Res 17(1):73, 2017
Berg SH, Rørtveit K, Walby FA, Aase K: Safe clinical practice for patients hospitalised in mental health wards during a suicidal crisis: qualitative study of patient experiences. BMJ Open 10(11):e040088, 2020
Bernanke J, McCommon B: Training in good psychiatric management for borderline personality disorder in residency: an aide to learning supportive psychotherapy for challenging-to-treat patients. Psychodyn Psychiatry 46(2):181–200, 2018
Bhola P, Mehrotra K: Associations between countertransference reactions towards patients with borderline personality disorder and therapist experience levels and mentalization ability. Trends Psychiatry Psychother 43(2):116–125, 2021
Bianchini V, Cofini V, Curto M, et al: Dialectical behaviour therapy (DBT) for forensic psychiatric patients: an Italian pilot study. Crim Behav Ment Health 29(2):122–130, 2019
Bjureberg J, Ljótsson B, Tull MT, et al: Development and validation of a brief version of the Difficulties in Emotion Regulation Scale: the DERS-16. J Psychopathol Behav Assess 38(2):284–296, 2016
Black T: The Assessment of Suicide and Risk Inventory. Tyler Black, 2013. Available at: http://www.asari.ca. Accessed January 31, 2023.
Black DW, Blum N, Pfohl B, Hale N: Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention. J Pers Disord 18(3):226–239, 2004
Black DW, Gunter T, Allen J, et al: Borderline personality disorder in male and female offenders newly committed to prison. Compr Psychiatry 48(5):400–405, 2007
Black DW, Blum N, McCormick B, Allen J: Systems Training for Emotional Predictability and Problem Solving (STEPPS) group treatment for offenders with borderline personality disorder. J Nerv Ment Dis 201(2):124–129, 2013
Black DW, Zanarini MC, Romine A, et al: Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 171(11):1174–1182, 2014
Black DW, Blum N, Allen J: Does response to the STEPPS program differ by sex, age, or race in offenders with borderline personality disorder? Compr Psychiatry 87:134–137, 2018
Blum N, St John D, Pfohl B, et al: Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. Am J Psychiatry 165(4):468–478, 2008
Bo S, Vilmar JW, Jensen SL, et al: What works for adolescents with borderline personality disorder: towards a developmentally informed understanding and structured treatment model. Curr Opin Psychol 37:7–12, 2021
Bogenschutz MP, Nurnberg HG: Olanzapine versus placebo in the treatment of borderline personality disorder. J Clin Psychiatry 65(1):104–109, 2004
Bohus M, Haaf B, Simms T, et al: Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial. Behav Res Ther 42(5):487–499, 2004
Bohus M, Limberger MF, Frank U, et al: Psychometric properties of the Borderline Symptom List (BSL). Psychopathology 40(2):126–132, 2007
Bohus M, Kleindienst N, Limberger MF, et al: The short version of the Borderline Symptom List (BSL-23): development and initial data on psychometric properties. Psychopathology 42(1):32–39, 2009
Bohus M, Dyer AS, Priebe K, et al: Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom 82(4):221–233, 2013
Bohus M, Kleindienst N, Hahn C, et al: Dialectical behavior therapy for posttraumatic stress disorder (DBT-PTSD) compared with cognitive processing therapy (CPT) in complex presentations of PTSD in women survivors of childhood abuse: a randomized clinical trial. JAMA Psychiatry 77(12):1235–1245, 2020
Bohus M, Stoffers-Winterling J, Sharp C, et al: Borderline personality disorder. Lancet 398(10310):1528–1540, 2021
Boritz T, Barnhart R, McMain SF: The influence of posttraumatic stress disorder on treatment outcomes of patients with borderline personality disorder. J Pers Disord 30(3):395–407, 2016
Bos EH, van Wel EB, Appelo MT, et al: A randomized controlled trial of a Dutch version of systems training for emotional predictability and problem solving for borderline personality disorder. J Nerv Ment Dis 198(4):299–304, 2010
Botter L, Ten Have M, Gerritsen D, et al: Impact of borderline personality disorder traits on the association between age and health-related quality of life: a cohort study in the general population. Eur Psychiatry 64(1):e33, 2021
Bozzatello P, Bellino S: Interpersonal psychotherapy as a single treatment for borderline personality disorder: a pilot randomized-controlled study. Front Psychiatry 11:578910, 2020
Bozzatello P, Rocca P, Uscinska M, et al: Efficacy and tolerability of asenapine compared with olanzapine in borderline personality disorder: an open-label randomized controlled trial. CNS Drugs 31(9):809–819, 2017
Brand BL, Lanius RA: Chronic complex dissociative disorders and borderline personality disorder: disorders of emotion dysregulation? Borderline Personal Disord Emot Dysregul 1:13, 2014
Bridler R, Häberle A, Müller ST, et al: Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: a comparison with other psychiatric disorders. Eur Neuropsychopharmacol 25(6):763–772, 2015
Brito JP, Domecq JP, Murad MH, et al: The Endocrine Society guidelines: when the confidence cart goes before the evidence horse. J Clin Endocrinol Metab 98(8):3246–3252, 2013
Burns CJ, Borah L, Terrell SM, et al: Trauma-informed care curricula for the health professions: a scoping review of best practices for design, implementation, and evaluation. Acad Med 98(3):401–409, 2023
Busch AJ, Balsis S, Morey LC, et al: Gender differences in borderline personality disorder features in an epidemiological sample of adults age 55–64: self versus informant report. J Pers Disord 30(3):419–432, 2016
Cailhol L, Roussignol B, Klein R, et al: Borderline personality disorder and rTMS: a pilot trial. Psychiatry Res 216(1):155–157, 2014
Caligor E, Kernberg OK, Clarkin JF, et al: Psychodynamic Therapy for Personality Pathology: Treating Self and Interpersonal Functioning. Washington, DC, American Psychiatric Association Publishing, 2018
Canadian Agency for Drugs and Technologies in Health: Treatment of Personality Disorders in Adults With or Without Comorbid Mental Health Conditions: Clinical Effectiveness and Guidelines. (CADTH Rapid Response Report: Summary of Abstracts). Ottawa, Canada, Canadian Agency for Drugs and Technologies in Health, February 2018. Available at: https://www.cadth.ca/sites/default/files/pdf/htis/2018/RB1199%20Personality%20Disorders%20Final.pdf. Accessed April 28, 2023.
Carlyle D, Green R, Inder M, et al: A randomized-controlled trial of mentalization-based treatment compared with structured case management for borderline personality disorder in a mainstream public health service. Front Psychiatry 11:561916, 2020
Carmona i Farrés C, Elices M, Soler J, et al: Effects of mindfulness training on borderline personality disorder: Impulsivity versus emotional dysregulation. Mindfulness 10:1243–1254, 2019a
Carmona I Farrés C, Elices M, Soler J, et al: Effects of mindfulness training on the default mode network in borderline personality disorder. Clin Psychol Psychother 26(5):562–571, 2019b
Carpenter RW, Wood PK, Trull TJ: Comorbidity of borderline personality disorder and lifetime substance use disorders in a nationally representative sample. J Pers Disord 30(3):336–350, 2016
Carter GL, Willcox CH, Lewin TJ, et al: Hunter DBT project: randomized controlled trial of dialectical behaviour therapy in women with borderline personality disorder. Aust N Z J Psychiatry 44(2):162–173, 2010
Casiano H, Katz LY, Globerman D, et al: Suicide and deliberate self-injurious behavior in juvenile correctional facilities: a review. J Can Acad Child Adolesc Psychiatry 22(2):118–124, 2013
Center for Health Policy/Center for Primary Care and Outcomes Research and Battelle Memorial Institute: Quality Indicator Measure Development, Implementation, Maintenance, and Retirement. Contract No 290-04-0020. Rockville, MD, Agency for Healthcare Research and Quality, 2011
Center for Substance Abuse Treatment: Trauma-Informed Care in Behavioral Health Services (Treatment Improvement Protocol [TIP]) Series, No 57). Rockville, MD, Substance Abuse and Mental Health Services Administration, 2014
Centers for Medicare and Medicaid Services: Blueprint measure lifecycle, in Measures Management System Hub. Baltimore, MD, Centers for Medicare and Medicaid Services, March 2023. Available at: https://mmshub.cms.gov/measure-lifecycle/measure-specification/overview. Accessed May 7, 2023.
Central Institute of Mental Health: Information and Downloads: Psychosomatic Medicine and Psychotherapy. BSL-23 / BSL-95—Questionnaires. Mannheim, Germany, Central Institute of Mental Health, 2020. Available at: https://www.zi-mannheim.de/en/forschung/abteilungen-ags-institute/psm/information-and-downloads-psychosomatic-medicine-and-psychotherapy.html. Accessed January 4, 2023.
Ceresa A, Esposito CM, Buoli M: How does borderline personality disorder affect management and treatment response of patients with major depressive disorder? A comprehensive review. J Affect Disord 281:581–589, 2021
Chanen AM, Thompson KN: Prescribing and borderline personality disorder. Aust Prescr 39(2):49–53, 2016
Chanen AM, Jackson HJ, McCutcheon LK, et al: Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial. Br J Psychiatry 193(6):477–484, 2008
Chanen AM, Betts JK, Jackson H, et al: Effect of 3 forms of early intervention for young people with borderline personality disorder: the MOBY randomized clinical trial. JAMA Psychiatry 79(2):109–119, 2022
Chen EY, Brown MZ, Harned MS, et al: A comparison of borderline personality disorder with and without eating disorders. Psychiatry Res 170(1):86–90, 2009
Chen PH, Tsai SY, Chen PY, et al: Mood stabilizers and risk of all-cause, natural, and suicide mortality in bipolar disorder: a nationwide cohort study. Acta Psychiatr Scand 147(3):234–247, 2023
Cheney L, Dudas RB, Traynor JM, et al: Co-occurring autism spectrum and borderline personality disorder: an emerging clinical challenge seeking informed interventions. Harv Rev Psychiatry 31(2):83–91, 2023
Chengappa KN, Ebeling T, Kang JS, et al: Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry 60(7):477–484, 1999
Chiappini S, Picutti E, Alessi MC, et al: Efficacy of noninvasive brain stimulation on borderline personality disorder core symptoms: a systematic review. J Pers Disord 36(5):505–526, 2022
Chisolm MS, Payne JL: Management of psychotropic drugs during pregnancy. BMJ 532:h5918, 2016
Choi-Kain LW, Albert EB, Gunderson JG: Evidence-based treatments for borderline personality disorder: implementation, integration, and stepped care. Harv Rev Psychiatry 24(5):342–356, 2016
Choi-Kain LW, Finch EF, Masland SR, et al: What works in the treatment of borderline personality disorder. Curr Behav Neurosci Rep 4(1):21–30, 2017
Choi-Kain LW, Sahin Z, Traynor J: Borderline personality disorder: updates in a postpandemic world. Focus Am Psychiatr Publ 20(4):337–352, 2022
Cipriano A, Cella S, Cotrufo P: Nonsuicidal self-injury: a systematic review. Front Psychol 8:1946, 2017
Clarke DE, Wilcox HC, Miller L, et al: Feasibility and acceptability of the DSM-5 Field Trial procedures in the Johns Hopkins Community Psychiatry Programs. Int J Methods Psychiatr Res 23(2):267–278, 2014
Clarkin JF, Levy KN, Lenzenweger MF, et al: Evaluating three treatments for borderline personality disorder: a multiwave study. Am J Psychiatry 164(6):922–928, 2007
Clausen W, Watanabe-Galloway S, Bill Baerentzen M, et al: Health literacy among people with serious mental illness. Community Ment Health J 52(4):399–405, 2016
Cohen AN, Drapalski AL, Glynn SM, et al: Preferences for family involvement in care among consumers with serious mental illness. Psychiatr Serv 64(3):257–263, 2013
Cohen AN, Hamilton AB, Saks ER, et al: How occupationally high-achieving individuals with a diagnosis of schizophrenia manage their symptoms. Psychiatr Serv 68(4):324–329, 2017
Comtois KA, Carmel A: Borderline personality disorder and high utilization of inpatient psychiatric hospitalization: concordance between research and clinical diagnosis. J Behav Health Serv Res 43(2):272–280, 2016
Copeland ME: Wellness recovery action plan. Occup Ther Ment Health 17:3–4, 127–150, 2000
Cottraux J, Note ID, Boutitie F, et al: Cognitive therapy versus Rogerian supportive therapy in borderline personality disorder: two-year follow-up of a controlled pilot study. Psychother Psychosom 78(5):307–316, 2009
Council of Medical Specialty Societies: Principles for the Development of Specialty Society Clinical Guidelines. Chicago, IL, Council of Medical Specialty Societies, 2017
Courtois CA, Brown LS, Cook J, et al: Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults. Washington, DC, American Psychological Association Guideline Development Panel for the Treatment of PTSD in Adults, 2017
Cowdry RW, Gardner DL: Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry 45(2):111–119, 1988
Crawford MJ, Sanatinia R, Barrett B, et al: The clinical effectiveness and cost-effectiveness of lamotrigine in borderline personality disorder: a randomized placebo-controlled trial. Am J Psychiatry 175(8):756–764, 2018
Crawford MJ, Leeson VC, Evans R, et al: The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial. Ther Adv Psychopharmacol 12:20451253221090832, 2022
Cuijpers P, Veen SCV, Sijbrandij M, et al: Eye movement desensitization and reprocessing for mental health problems: a systematic review and meta-analysis. Cogn Behav Ther 49(3):165–180, 2020
Culina I, Fiscalini E, Martin-Soelch C, et al: The first session matters: therapist responsiveness and the therapeutic alliance in the treatment of borderline personality disorder. Clin Psychol Psychother 30(1):131–140, 2023
Davidson K, Norrie J, Tyrer P, et al: The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the Borderline Personality Disorder Study of Cognitive Therapy (BOSCOT) trial. J Pers Disord 20(5):450–465, 2006
Davidson KM, Brown TM, James V, et al: Manual-assisted cognitive therapy for self-harm in personality disorder and substance misuse: a feasibility trial. Psychiatr Bull 38:108–111, 2014
de Aquino Ferreira LF, Queiroz Pereira FH, Neri Benevides AML, et al: Borderline personality disorder and sexual abuse: a systematic review. Psychiatry Res 262:70–77, 2018
de Freixo Ferreira L, Guerra C, Vieira-Coelho MA: Predictors of psychotherapy dropout in patients with borderline personality disorder: a systematic review. Clin Psychol Psychother 30(6):1324–1337, 2023
de la Fuente JM, Lotstra F: A trial of carbamazepine in borderline personality disorder. Eur Neuropsychopharmacol 4(4):479–486, 1994
De Los Reyes A, Augenstein TM, Wang M, et al: The validity of the multi-informant approach to assessing child and adolescent mental health. Psychol Bull 141(4):858–900, 2015
Dean K, Singh S, Soon YL: Decriminalizing severe mental illness by reducing risk of contact with the criminal justice system, including for forensic patients. CNS Spectr 25(5):687–700, 2020
Denning DM, Newlands RT, Gonzales A, et al: Borderline personality disorder symptoms in a community sample of sexually and gender diverse adults. J Pers Disord 36(6):701–716, 2022
Department of Veterans Affairs/Department of Defense: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder. Washington, DC, U.S. Government Printing Office, 2022
Department of Veterans Affairs/Department of Defense: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder. Washington, DC, U.S. Government Printing Office, 2023
DesRoches CM, Leveille S, Bell SK, et al: The views and experiences of clinicians sharing medical record notes with patients. JAMA Netw Open 3(3):e201753, 2020
Dixon LB, Holoshitz Y, Nossel I: Treatment engagement of individuals experiencing mental illness: review and update. World Psychiatry 15(1):13–20, 2016
Djulbegovic B, Trikalinos TA, Roback J, et al: Impact of quality of evidence on the strength of recommendations: an empirical study. BMC Health Serv Res 9:120, 2009
Doering S: Borderline personality disorder in patients with medical illness: a review of assessment, prevalence, and treatment options. Psychosom Med 81(7):584–594, 2019
Doering S, Hörz S, Rentrop M, et al: Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial. Br J Psychiatry 196(5):389–395, 2010
Doyle M, While D, Mok PL, et al: Suicide risk in primary care patients diagnosed with a personality disorder: a nested case control study. BMC Fam Pract 17:106, 2016
Draine J, Blank Wilson A, Metraux S, et al: The impact of mental illness status on the length of jail detention and the legal mechanism of jail release. Psychiatr Serv 61(5):458–462, 2010
Drake R, Skinner J, Goldman HH: What explains the diffusion of treatments for mental illness? Am J Psychiatry 165(11):1385–1392, 2008
Durdurak BB, Altaweel N, Upthegrove R, et al: Understanding the development of bipolar disorder and borderline personality disorder in young people: a meta-review of systematic reviews. Psychol Med 52(16):1–14, 2022
Edwards ER, Tran H, Wrobleski J, et al: Prevalence of personality disorders across veteran samples: a meta-analysis. J Pers Disord 36(3):339–358, 2022
El-Gabalawy R, Katz LY, Sareen J: Comorbidity and associated severity of borderline personality disorder and physical health conditions in a nationally representative sample. Psychosom Med 72(7):641–647, 2010
Elices M, Pascual JC, Portella MJ, et al: Impact of mindfulness training on borderline personality disorder: a randomized trial. Mindfulness 7:584–595, 2016
Ellison WD, Rosenstein LK, Morgan TA, et al: Community and clinical epidemiology of borderline personality disorder. Psychiatr Clin North Am 41(4):561–573, 2018
Emotions Matter: Emotions Matter BPD Advocacy Awareness Connection. Garden City, NY, Emotions Matter Inc, 2023a. Available at: https://emotionsmatterbpd.org. Accessed August 30, 2023.
Emotions Matter: Emotions Matter’s BPD Peer Online Support Group Program. Garden City, NY, Emotions Matter Inc, 2023b. Available at: https://emotionsmatterbpd.org/peer-support-groups-information. Accessed September 2, 2023.
Epshteyn I, Mahmoud H: Enhancing mental health treatment for borderline personality disorder in corrections. J Correct Health Care 27(4):220–225, 2021
Epstein RS: Keeping Boundaries: Maintaining Safety and Integrity in the Psychotherapeutic Process. Washington, DC, American Psychiatric Publishing Inc, 1994
Farrell JM, Shaw IA, Webber MA: A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial. J Behav Ther Exp Psychiatry 40(2):317–328, 2009
Favril L, Yu R, Hawton K, Fazel S: Risk factors for self-harm in prison: a systematic review and meta-analysis. Lancet Psychiatry 7(8):682–691, 2020
Feffer K, Lee HH, Wu W, et al: Dorsomedial prefrontal rTMS for depression in borderline personality disorder: a pilot randomized crossover trial. J Affect Disord 301:273–280, 2022
Feigenbaum JD, Fonagy P, Pilling S, et al: A real-world study of the effectiveness of DBT in the UK National Health Service. Br J Clin Psychol 51(2):121–141, 2012
Fernandes-Taylor S, Harris AH: Comparing alternative specifications of quality measures: access to pharmacotherapy for alcohol use disorders. J Subst Abuse Treat 42(1):102–107, 2012
Ferri M, Amato L, Davoli M: Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database Syst Rev (3):CD005032, 2006
Feske U, Mulsant BH, Pilkonis PA, et al: Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. Am J Psychiatry 161(11):2073–2080, 2004
Fineberg SK, Gupta S, Leavitt J: Collaborative deprescribing in borderline personality disorder: a narrative review. Harv Rev Psychiatry 27(2):75–86, 2019
Fineberg SK, Choi EY, Shapiro-Thompson R, et al: A pilot randomized controlled trial of ketamine in Borderline Personality Disorder. Neuropsychopharmacology 48(7):991–999, 2023
Finnish Medical Society Duodecim: Borderline personality disorder. current care summary. Duodecim Current Care Guidelines, August 6, 2020. Available at: https://www.kaypahoito.fi/en/ccs00043. Accessed April 28, 2023.
Firth J, Siddiqi N, Koyanagi A, et al: The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry 6(8):675–712, 2019
Fliege H, Kocalevent RD, Walter OB, et al: Three assessment tools for deliberate self-harm and suicide behavior: evaluation and psychopathological correlates. J Psychosom Res 61(1):113–121, 2006
Fonagy P, Speranza M, Luyten P, et al: ESCAP Expert Article: borderline personality disorder in adolescence: an expert research review with implications for clinical practice. Eur Child Adolesc Psychiatry 24(11):1307–1320, 2015
Ford JD, Courtois CA: Complex PTSD and borderline personality disorder. Borderline Personal Disord Emot Dysregul 8(1):16, 2021
Fornaro M, Orsolini L, Marini S, et al: The prevalence and predictors of bipolar and borderline personality disorders comorbidity: systematic review and meta-analysis. J Affect Disord 195:105–118, 2016
Fortney JC, Unützer J, Wrenn G, et al: A tipping point for measurement-based care. Psychiatr Serv 68(2):179–188, 2017
Fountoulakis KN, Tohen M, Zarate CA Jr: Lithium treatment of bipolar disorder in adults: a systematic review of randomized trials and meta-analyses. Eur Neuropsychopharmacol 54:100–115, 2022
Fowler JC, Charak R, Elhai JD, et al: Construct validity and factor structure of the Difficulties in Emotion Regulation Scale among adults with severe mental illness. J Psychiatr Res 58:175–180, 2014
Fowler JC, Clapp JD, Madan A, et al: A naturalistic longitudinal study of extended inpatient treatment for adults with borderline personality disorder: an examination of treatment response, remission and deterioration. J Affect Disord 235:323–331, 2018
Frank JD, Frank JB: Persuasion and Healing: A Comparative Study of Psychotherapy, 3rd Edition. Baltimore, MD, The Johns Hopkins University Press, 1993
Frankenburg FR, Zanarini MC: Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. J Clin Psychiatry 63(5):442–446, 2002
Frei-Lanter CM, Vavricka SR, Kruger TH, et al: Endoscopy for repeatedly ingested sharp foreign bodies in patients with borderline personality disorder: an international survey. Eur J Gastroenterol Hepatol 24(7):793–797, 2012
Friborg O, Martinsen EW, Martinussen M, et al: Comorbidity of personality disorders in mood disorders: a meta-analytic review of 122 studies from 1988 to 2010. J Affect Disord 152–154:1–11, 2014
Fries BE, Schmorrow A, Lang SW, et al: Symptoms and treatment of mental illness among prisoners: a study of Michigan state prisons. Int J Law Psychiatry 36(3–4):316–325, 2013
Gabbard GO, Wilkinson SM: Management of Countertransference with Borderline Patients. Lanham, MD, Jason Aronson, 2000
Gabbard GO, Kassaw KA, Perez-Garcia G: Professional boundaries in the era of the internet. Acad Psychiatry 35(3):168–174, 2011
Gaily-Luoma S, Valkonen J, Holma J, et al: How do health care services help and hinder recovery after a suicide attempt? A qualitative analysis of Finnish service user perspectives. Int J Ment Health Syst 16(1):52, 2022
García-Carmona JA, Simal-Aguado J, Campos-Navarro MP, et al: Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain. Int Clin Psychopharmacol 36(4):201–207, 2021
Gardner DL, Cowdry RW: Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder. Am J Psychiatry 143(4):519–522, 1986
Gartlehner G, West SL, Mansfield AJ, et al: Clinical heterogeneity in systematic reviews and health technology assessments: synthesis of guidance documents and the literature. Int J Technol Assess Health Care 28(1):36–43, 2012
Gartlehner G, Crotty K, Kennedy S, et al: Pharmacological treatments for borderline personality disorder: a systematic review and meta-analysis. CNS Drugs 35(10):1053–1067, 2021
Geluk Rouwhorst A, Ten Have M, de Graaf R, et al: The impact of borderline personality disorder symptoms on onset and course of anxiety disorders: results of a general population study. Personal Disord 14(3):360–368, 2023
Giesen-Bloo J, van Dyck R, Spinhoven P, et al: Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry 63(6):649–658, 2006
Giourou E, Skokou M, Andrew SP, et al: Complex posttraumatic stress disorder: the need to consolidate a distinct clinical syndrome or to reevaluate features of psychiatric disorders following interpersonal trauma? World J Psychiatry 8(1):12–19, 2018
Glowa-Kollisch S, Kaba F, Waters A, et al: From punishment to treatment: the “Clinical Alternative to Punitive Segregation” (CAPS) program in New York City jails. Int J Environ Res Public Health 13(2):182, 2016
Goldhammer H, Crall C, Keuroghlian AS: Distinguishing and addressing gender minority stress and borderline personality symptoms. Harv Rev Psychiatry 27(5):317–325, 2019
González-González S, Marañón-González R, Hoyuela-Zatón F, et al: STEPPS for borderline personality disorder: a pragmatic trial and naturalistic comparison with noncompleters. J Pers Disord 35(6):841–856, 2021
Goodman M, Tomas IA, Temes CM, et al: Suicide attempts and self-injurious behaviours in adolescent and adult patients with borderline personality disorder. Personal Ment Health 11(3):157–163, 2017
Grambal A, Prasko J, Ociskova M, et al: Borderline personality disorder and unmet needs. Neuroendocrinol Lett 38(4):275–289, 2017
Grant BF, Chou SP, Goldstein RB, et al: Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 69(4):533–545, 2008
Grant BF, Saha TD, Ruan WJ, et al: Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions–III. JAMA Psychiatry 73(1):39–47, 2016
Gratz KL: Measurement of deliberate self-harm: preliminary data on the Deliberate Self-Harm Inventory. J Psychopathol Behav Assess 23(4):253–263, 2001
Gratz KL, Gunderson JG: Preliminary data on an acceptance-based emotion regulation group intervention for deliberate self-harm among women with borderline personality disorder. Behav Ther 37(1):25–35, 2006
Gratz KL, Roemer L: Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess 26(1):41–54, 2004
Gratz KL, Tull MT, Levy R: Randomized controlled trial and uncontrolled 9-month follow-up of an adjunctive emotion regulation group therapy for deliberate self-harm among women with borderline personality disorder. Psychol Med 44(10):2099–2112, 2014
Greenhalgh T, Robert G, Macfarlane F, et al: Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q 82(4):581–629, 2004
Gregory RJ: Clinical, Training, and Research Manual of Dynamic Deconstructive Psychotherapy v. 07.05.22. Syracuse, NY, Robert J. Gregory, M.D., 2022. Available at: https://www.upstate.edu/psych/pdf/manual.pdf. Accessed April 20, 2023.
Gregory RJ, Remen AL: A manual-based psychodynamic therapy for treatment-resistant borderline personality disorder. Psychotherapy (Chic) 45(1):15–27, 2008
Gregory RJ, Sachdeva S: Naturalistic outcomes of evidence-based therapies for borderline personality disorder at a medical university clinic. Am J Psychother 70(2):167–184, 2016
Gregory RJ, Chlebowski S, Kang D, et al: A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder. Psychotherapy (Chic) 45(1):28–41, 2008
Gregory RJ, Remen AL, Soderberg M, et al: A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder: six-month outcome. J Am Psychoanal Assoc 57(1):199–205, 2009
Gregory RJ, DeLucia-Deranja E, Mogle JA: Dynamic deconstructive psychotherapy versus optimized community care for borderline personality disorder co-occurring with alcohol use disorders: a 30-month follow-up. J Nerv Ment Dis 198(4):292–298, 2010
Gremaud-Heitz D, Riemenschneider A, Walter M, et al: Comorbid atypical depression in borderline personality disorder is common and correlated with anxiety-related psychopathology. Compr Psychiatry 55(3):650–656, 2014
Griengl H, Sendera A, Dantendorfer K: Naltrexone as a treatment of self-injurious behavior: a case report. Acta Psychiatr Scand 103(3):234–236, 2001
Grilo CM, Udo T: Association of borderline personality disorder criteria with suicide attempts among US adults. JAMA Netw Open 4(5):e219389, 2021
Gross R, Olfson M, Gameroff M, et al: Borderline personality disorder in primary care. Arch Intern Med 162(1):53–60, 2002
Guillén Botella V, García-Palacios A, Bolo Miñana S, et al: Exploring the effectiveness of dialectical behavior therapy versus systems training for emotional predictability and problem solving in a sample of patients with borderline personality disorder. J Pers Disord 35(Suppl A):21–38, 2021
Gunderson JG: Borderline personality disorder: ontogeny of a diagnosis. Am J Psychiatry 166(5):530–539, 2009
Gunderson JG, Berkowitz C: Borderline Personality Disorder Family Guidelines. Washington, NJ, National Education Alliance for Borderline Personality Disorder, 1991. Available at: https://www.borderlinepersonalitydisorder.org/family connections/family guidelines. Accessed March 1, 2023.
Gunderson JG, Stout RL, Sanislow CA, et al: New episodes and new onsets of major depression in borderline and other personality disorders. J Affect Disord 111(1):40–45, 2008
Gunderson JG, Stout RL, McGlashan TH, et al: Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry 68(8):827–837, 2011
Gunderson JG, Stout RL, Shea MT, et al: Interactions of borderline personality disorder and mood disorders over 10 years. J Clin Psychiatry 75(8):829–834, 2014
Gunderson J, Masland S, Choi-Kain L: Good psychiatric management: a review. Curr Opin Psychol 21:127–131, 2018
Gutheil TG: Boundary issues and personality disorders. J Psychiatr Pract 11(2):88–96, 2005
Guyatt G, Gutterman D, Baumann MH, et al: Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest 129(1):174–181, 2006
Guyatt GH, Oxman AD, Kunz R, et al: Going from evidence to recommendations. BMJ 336:1049–1051, 2008
Guyatt G, Eikelboom JW, Akl EA, et al: A guide to GRADE guidelines for the readers of JTH. J Thromb Haemost 11(8):1603–1608, 2013
Ha C, Balderas JC, Zanarini MC, et al: Psychiatric comorbidity in hospitalized adolescents with borderline personality disorder. J Clin Psychiatry 75(5):e457–e464, 2014
Hailes HP, Yu R, Danese A, et al: Long-term outcomes of childhood sexual abuse: an umbrella review. Lancet Psychiatry 6(10):830–839, 2019
Hallion LS, Steinman SA, Tolin DF, et al: Psychometric properties of the Difficulties in Emotion Regulation Scale (DERS) and its short forms in adults with emotional disorders. Front Psychol 9:539, 2018
Hamann J, Heres S: Why and how family caregivers should participate in shared decision making in mental health. Psychiatr Serv 70(5):418–421, 2019
Harding KJ, Rush AJ, Arbuckle M, et al: Measurement-based care in psychiatric practice: a policy framework for implementation. J Clin Psychiatry 72(8):1136–1143, 2011
Harford TC, Chen CM, Kerridge BT, et al: Borderline personality disorder and violence toward self and others: a national study. J Pers Disord 33(5):653–670, 2019
Harned MS, Valenstein HR: Treatment of borderline personality disorder and co-occurring anxiety disorders. F1000Prime Rep 5:15, 2013
Harned MS, Korslund KE, Linehan MM: A pilot randomized controlled trial of dialectical behavior therapy with and without the dialectical behavior therapy prolonged exposure protocol for suicidal and self-injuring women with borderline personality disorder and PTSD. Behav Res Ther 55:7–17, 2014
Harned MS, Wilks CR, Schmidt SC, et al: Improving functional outcomes in women with borderline personality disorder and PTSD by changing PTSD severity and post-traumatic cognitions. Behav Res Ther 103:53–61, 2018
Hastrup LH, Jennum P, Ibsen R, et al: Societal costs of borderline personality disorders: a matched-controlled nationwide study of patients and spouses. Acta Psychiatr Scand 140(5):458–467, 2019
Hazlehurst JM, Armstrong MJ, Sherlock M, et al: A comparative quality assessment of evidence-based clinical guidelines in endocrinology. Clin Endocrinol (Oxf) 78(2):183–190, 2013
Health Standards Organization: Leading Practices: Assessment of Suicide and Risk Inventory (ASARI) Documentation Tool. Ottawa, ON, Health Standards Organization, 2023. Available at: https://healthstandards.org/leading-practice/assessment-of-suicide-and-risk-inventory-asari-documentation-tool. Accessed February 15, 2023.
Heath LM, Laporte L, Paris J, et al: Substance misuse is associated with increased psychiatric severity among treatment-seeking individuals with borderline personality disorder. J Pers Disord 32(5):694–708, 2018a
Heath LM, Paris J, Laporte L, Gill KJ: High prevalence of physical pain among treatment-seeking individuals with borderline personality disorder. J Pers Disord 32(3):414–420, 2018b
Hein M, Mungo A, Loas G: Nonremission after electroconvulsive therapy in individuals with major depression: role of borderline personality disorder. J ECT 38(4):238–243, 2022a
Hein M, Mungo A, Loas G: Risk of relapse within 6 months associated with borderline personality disorder in major depressed individuals treated with electroconvulsive therapy. Psychiatry Res 314:114650, 2022b
Herpertz SC, Zanarini M, Schulz CS, et al: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry 8(4):212–244, 2007. Available at: https://wfsbp.org/wp-content/uploads/2023/02/Guidelines_Personality_ Disorders.pdf. Accessed April 28, 2023.
Herpertz SC, Matzke B, Hillmann K, et al: A mechanism-based group-psychotherapy approach to aggressive behaviour in borderline personality disorder: findings from a cluster-randomised controlled trial. BJPsych Open 7(1):e17, 2020
Hersh R, Caligor E, Yeomans FE, et al: Fundamentals of TFP: Applications in Psychiatric and General Medical Settings. New York, Springer, 2017
Hilden HM, Rosenström T, Karila I, et al: Effectiveness of brief schema group therapy for borderline personality disorder symptoms: a randomized pilot study. Nord J Psychiatry 75(3):176–185, 2021
Høgh Egmose C, Heinsvig Poulsen C, Hjorthøj C, et al: The effectiveness of peer support in personal and clinical recovery: systematic review and meta-analysis. Psychiatr Serv 74(8):847–858, 2023
Hollander E, Allen A, Lopez RP, et al: A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry 62(3):199–203, 2001
Hong V: Borderline personality disorder in the emergency department: good psychiatric management. Harv Rev Psychiatry 24(5):357–366, 2016
Horvitz-Lennon M, Donohue JM, Domino ME, et al: Improving quality and diffusing best practices: the case of schizophrenia. Health Aff (Millwood) 28(3):701–712, 2009a
Horvitz-Lennon M, Reynolds S, Wolbert R, et al: The role of assertive community treatment in the treatment of people with borderline personality disorder. Am J Psychiatr Rehabil 12(3):261–277, 2009b
Howard R, Hasin D, Stohl M: Substance use disorders and criminal justice contact among those with co-occurring antisocial and borderline personality disorders: findings from a nationally representative sample. Personal Ment Health 15(1):40–48, 2021
Hudays A, Gallagher R, Hazazi A, et al: Eye movement desensitization and reprocessing versus cognitive behavior therapy for treating post-traumatic stress disorder: a systematic review and meta-analysis. Int J Environ Res Public Health 19(24):16836, 2022
Huo Y, Couzner L, Windsor T, et al: Barriers and enablers for the implementation of trauma-informed care in healthcare settings: a systematic review. Implement Sci Commun 4(1):49, 2023
Hutsebaut J, Feenstra DJ, Kamphuis JH: Development and preliminary psychometric evaluation of a brief self-report questionnaire for the assessment of the DSM-5 level of Personality Functioning Scale: the LPFS Brief Form (LPFS-BF). Personal Disord 7(2):192–197, 2016
Ilagan GS, Choi-Kain LW: General psychiatric management for adolescents (GPM-A) with borderline personality disorder. Curr Opin Psychol 37:1–6, 2021
Iliakis EA, Sonley AKI, Ilagan GS, et al: Treatment of borderline personality disorder: is supply adequate to meet public health needs? Psychiatr Serv 70(9):772–781, 2019
Iliakis EA, Ilagan GS, Choi-Kain LW: Dropout rates from psychotherapy trials for borderline personality disorder: a meta-analysis. Personal Disord 12(3):193–206, 2021
Institute for Safe Medication Practice: Implement strategies to prevent persistent medication errors and hazards. Institute for Safe Medication Practices, March 23, 2023. Available at: https://www.ismp.org/resources/implement-strategies-prevent-persistent-medication-errors-and-hazards. Accessed April 4, 2023.
Institute of Medicine: Committee on Quality of Health Care in America: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC, National Academies Press, 2001
Institute of Medicine: Clinical Practice Guidelines We Can Trust. Washington, DC, National Academies Press, 2011
Iyer SP, Spaeth-Rublee B, Pincus HA: Challenges in the operationalization of mental health quality measures: an assessment of alternatives. Psychiatr Serv 67(10):1057–1059, 2016
Johnson KB, Neuss MJ, Detmer DE: Electronic health records and clinician burnout: a story of three eras. J Am Med Inform Assoc 28(5):967–973, 2021
Jørgensen CR, Freund C, Bøye R, et al: Outcome of mentalization-based and supportive psychotherapy in patients with borderline personality disorder: a randomized trial. Acta Psychiatr Scand 127(4):305–317, 2013
Jørgensen MS, Storebø OJ, Stoffers-Winterling JM, et al: Psychological therapies for adolescents with borderline personality disorder (BPD) or BPD features: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis. PLoS One 16(1):e0245331, 2021
Jowett S, Karatzias T, Albert I: Multiple and interpersonal trauma are risk factors for both post-traumatic stress disorder and borderline personality disorder: a systematic review on the traumatic backgrounds and clinical characteristics of comorbid post-traumatic stress disorder/borderline personality disorder groups versus single-disorder groups. Psychol Psychother 93(3):621–638, 2020a
Jowett S, Karatzias T, Shevlin M, et al: Differentiating symptom profiles of ICD-11 PTSD, complex PTSD, and borderline personality disorder: a latent class analysis in a multiply traumatized sample. Personal Disord 11(1):36–45, 2020b
Juurlink TT, Vukadin M, Stringer B, et al: Barriers and facilitators to employment in borderline personality disorder: a qualitative study among patients, mental health practitioners and insurance physicians. PLoS One 14(7):e0220233, 2019
Kaba F, Lewis A, Glowa-Kollisch S, et al: Solitary confinement and risk of self-harm among jail inmates. Am J Public Health 104(3):442–447, 2014
Kadra-Scalzo G, Garland J, Miller S, et al: Comparing psychotropic medication prescribing in personality disorder between general mental health and psychological services: retrospective cohort study. BJPsych Open 7(2):e72, 2021
Kalira V, Treisman GJ, Clark MR: Borderline personality disorder and chronic pain: a practical approach to evaluation and treatment. Curr Pain Headache Rep 17(8):350, 2013
Kardas P, Lewek P, Matyjaszczyk M: Determinants of patient adherence: a review of systematic reviews. Front Pharmacol 4:91, 2013
Kaster TS, Goldbloom DS, Daskalakis ZJ, et al: Electroconvulsive therapy for depression with comorbid borderline personality disorder or post-traumatic stress disorder: a matched retrospective cohort study. Brain Stimul 11(1):204–212, 2018
Kaufman EA, Xia M, Fosco G, et al: The Difficulties in Emotion Regulation Scale Short Form (DERS-SF): validation and replication in adolescent and adult samples. J Psychopathol Behav Assess 38(3):443–455, 2016
Kay ML, Poggenpoel M, Myburgh CP, et al: Experiences of family members who have a relative diagnosed with borderline personality disorder. Curationis 41(1):e1–e9, 2018
Kedia SK, Ahuja N, Dillon PJ, et al: Efficacy of extended-release injectable naltrexone on alcohol use disorder treatment: a systematic review. J Psychoactive Drugs 55(2):233–245, 2023
Kemp K, Zelle H, Bonnie RJ: Embedding advance directives in routine care for persons with serious mental illness: implementation challenges. Psychiatr Serv 66(1):10–14, 2015
Kessler RC, McGonagle KA, Zhao S, et al: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 51(1):8–19, 1994
Keuroghlian AS, Gunderson JG, Pagano ME, et al: Interactions of borderline personality disorder and anxiety disorders over 10 years. J Clin Psychiatry 76(11):1529–1534, 2015
Keuroghlian AS, Palmer BA, Choi-Kain LW, et al: The effect of attending Good Psychiatric Management (GPM) workshops on attitudes toward patients with borderline personality disorder. J Pers Disord 30(4):567–576, 2016
Kjær JNR, Biskin R, Vestergaard C, et al: All-cause mortality of hospital-treated borderline personality disorder: a nationwide cohort study. J Pers Disord 34(6):723–735, 2020
Klein P, Fairweather AK, Lawn S: Structural stigma and its impact on healthcare for borderline personality disorder: a scoping review. Int J Ment Health Syst 16(1):48, 2022a
Klein P, Fairweather AK, Lawn S: The impact of educational interventions on modifying health practitioners’ attitudes and practice in treating people with borderline personality disorder: an integrative review. Syst Rev 11(1):108, 2022b
Kleindienst N, Limberger MF, Ebner-Priemer UW, et al: Dissociation predicts poor response to dialectial behavioral therapy in female patients with borderline personality disorder. J Pers Disord 25(4):432–447, 2011
Kleindienst N, Jungkunz M, Bohus M: A proposed severity classification of borderline symptoms using the Borderline Symptom List (BSL-23). Borderline Personal Disord Emot Dysregul 7(1):11, 2020
Klonsky ED, Glenn CR: Assessing the functions of non-suicidal self-injury: psychometric properties of the Inventory of Statements About Self-injury (ISAS). J Psychopathol Behav Assess 31(3):215–219, 2009
Koivisto M, Melartin T, Lindeman S: Self-invalidation in borderline personality disorder: a content analysis of patients’ verbalizations. Psychother Res 32(7):922–935, 2022
Kolla NJ, Meyer JH, Bagby RM, et al: Trait anger, physical aggression, and violent offending in antisocial and borderline personality disorders. J Forensic Sci 62(1):137–141, 2017
Konstantinou GN, Trevizol AP, Downar J, et al: Repetitive transcranial magnetic stimulation in patients with borderline personality disorder: a systematic review. Psychiatry Res 304:114145, 2021
Kramer U, Berger T, Kolly S, et al: Effects of motive-oriented therapeutic relationship in early-phase treatment of borderline personality disorder: a pilot study of a randomized trial. J Nerv Ment Dis 199(4):244–250, 2011
Kramer U, Kolly S, Berthoud L, et al: Effects of motive-oriented therapeutic relationship in a ten-session general psychiatric treatment of borderline personality disorder: a randomized controlled trial. Psychother Psychosom 83(3):176–186, 2014
Krause-Utz A: Dissociation, trauma, and borderline personality disorder. Borderline Personal Disord Emot Dysregul 9(1):14, 2022
Krueger RF, Hobbs KA: An overview of the DSM-5 Alternative Model of Personality Disorders. Psychopathology 53(3–4):126–132, 2020
Kvarstein EH, Pedersen G, Urnes Ø, et al: Changing from a traditional psychodynamic treatment programme to mentalization-based treatment for patients with borderline personality disorder: does it make a difference? Psychol Psychother 88(1):71–86, 2015
Lamont E, Dickens GL: Mental health services, care provision, and professional support for people diagnosed with borderline personality disorder: systematic review of service-user, family, and carer perspectives. J Ment Health 30(5):619–633, 2021
Laporte L, Paris J, Bergevin T, et al: Clinical outcomes of a stepped care program for borderline personality disorder. Personal Ment Health 12(3):252–264, 2018
Latimer S, Covic T, Tennant A: Co-calibration of deliberate self harm (DSH) behaviours: towards a common measurement metric. Psychiatry Res 200(1):26–34, 2012
Laurenssen EMP, Luyten P, Kikkert MJ, et al: Day hospital mentalization-based treatment v. specialist treatment as usual in patients with borderline personality disorder: randomized controlled trial. Psychol Med 48(15):2522–2529, 2018
Le Corff Y, Aluja A, Rossi G, et al: Construct validity of the Dutch, English, French, and Spanish LPFS-BF 2.0: measurement invariance across language and gender and criterion validity. J Pers Disord 36(6):662–679, 2022
Lee DJ, Witte TK, Bardeen JR, et al: A factor analytic evaluation of the Difficulties in Emotion Regulation Scale. J Clin Psychol 72(9):933–946, 2016
Lee JH, Kung S, Rasmussen KG, et al: Effectiveness of electroconvulsive therapy in patients with major depressive disorder and comorbid borderline personality disorder. J ECT 35(1):44–47, 2019
Leichsenring F, Leibing E, Kruse J, et al: Borderline personality disorder. Lancet 377:74–84, 2011
Leichsenring F, Masuhr O, Jaeger U, et al: Psychoanalytic-interactional therapy versus psychodynamic therapy by experts for personality disorders: a randomized controlled efficacy-effectiveness study in cluster b personality disorders. Psychother Psychosom 85(2):71–80, 2016
Leichsenring F, Heim N, Leweke F, et al: Borderline personality disorder: a review. JAMA 329(8):670–679, 2023
Lenzenweger MF, Lane MC, Loranger AW, et al: DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry 62(6):553–564, 2007
Leppänen V, Hakko H, Sintonen H, et al: Comparing effectiveness of treatments for borderline personality disorder in communal mental health care: The Oulu BPD study. Community Ment Health J 52(2):216–227, 2016
Lequesne ER, Hersh RG: Disclosure of a diagnosis of borderline personality disorder. J Psychiatr Pract 10(3):170–176, 2004
Lewis CC, Boyd M, Puspitasari A, et al: Implementing measurement-based care in behavioral health: a review. JAMA Psychiatry 76(3):324–335, 2019
Lewis-Fernández R, Aggarwal NK, Hinton L, et al (eds): DSM-5 Handbook on the Cultural Formulation Interview. Washington, DC, American Psychiatric Publishing, 2016
Lieslehto J, Tiihonen J, Lähteenvuo M, et al: Comparative effectiveness of pharmacotherapies for the risk of attempted or completed suicide among persons with borderline personality disorder. JAMA Netw Open 6(6):e2317130, 2023
Lin TJ, Ko HC, Wu JY, et al: The effectiveness of dialectical behavior therapy skills training group vs. cognitive therapy group on reducing depression and suicide attempts for borderline personality disorder in Taiwan. Arch Suicide Res 23(1):82–99, 2019
Linehan MM: Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, Guilford, 1993a
Linehan MM1993b: Skills Training Manual for Treating Borderline Personality Disorder. New York, Guilford, 1993b
Linehan MM, Dimeff LA, Reynolds SK, et al: Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend 67(1):13–26, 2002
Linehan MM, Comtois KA, Murray AM, et al: Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 63(7):757–766, 2006
Linehan MM, McDavid JD, Brown MZ, et al: Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 69(6):999–1005, 2008
Linehan MM, Korslund KE, Harned MS, et al: Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis. JAMA Psychiatry 72(5):475–482, 2015
Links PL: Handbook of Good Psychiatric Management (GPM) for Borderline Patients. Washington, DC, American Psychiatric Publishing, 2014
Links P, Steiner M, Boiago I, et al: Lithium therapy for borderline patients: preliminary findings. J Pers Disord 4:173–181, 1990
Links PS, Kolla NJ, Guimond T, et al: Prospective risk factors for suicide attempts in a treated sample of patients with borderline personality disorder. Can J Psychiatry 58(2):99–106, 2013
Links PS, Ross J, Gunderson JG: Promoting good psychiatric management for patients with borderline personality disorder. J Clin Psychol 71(8):753–763, 2015
Loew TH, Nickel MK, Muehlbacher M, et al: Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol 26(1):61–66, 2006
Lohman MC, Whiteman KL, Yeomans FE, et al: Qualitative analysis of resources and barriers related to treatment of borderline personality disorder in the United States. Psychiatr Serv 68(2):167–172, 2017
Lyng J, Swales MA, Hastings RP, et al: Standalone DBT group skills training versus standard (i.e., all modes) DBT for borderline personality disorder: a natural quasi-experiment in routine clinical practice. Community Ment Health J 56(2):238–250, 2020
Machado CDS, Ballester PL, Cao B, et al: Prediction of suicide attempts in a prospective cohort study with a nationally representative sample of the US population. Psychol Med 52(14):2985–2996, 2022
MacIntyre MR, Appel JM: Legal and ethics considerations in reporting sexual exploitation by previous providers. J Am Acad Psychiatry Law 48(2):166–175, 2020
MacKinnon R, Michels R, Buckley P: The Psychiatric Interview in Clinical Practice, 3rd Edition. Washington, DC, American Psychiatric Publishing, 2016
Maercker A, Cloitre M, Bachem R, et al: Complex post-traumatic stress disorder. Lancet 400(10345):60–72, 2022
Maharaj AS, Bhatt NV, Gentile JP: Bringing it in the room: addressing the impact of racism on the therapeutic alliance. Innov Clin Neurosci 18(7–9):39–43, 2021
Mammen O, Tew J, Painter T, et al: Communicating suicide risk to families of chronically suicidal borderline personality disorder patients to mitigate malpractice risk. Gen Hosp Psychiatry 67:51–57, 2020
Mannarino VS, Pereira DCS, Gurgel WS, et al: Self-embedding behavior in adults: a report of two cases and a systematic review. J Forensic Sci 62(4):953–961, 2017
Marino MF, Zanarini MC: Relationship between EDNOS and its subtypes and borderline personality disorder. Int J Eat Disord 29(3):349–353, 2001
Martin A, Naunton M, Kosari S, et al: Treatment guidelines for PTSD: a systematic review. J Clin Med 10(18):4175, 2021
Martinussen M, Friborg O, Schmierer P, et al: The comorbidity of personality disorders in eating disorders: a meta-analysis. Eat Weight Disord 22(2):201–209, 2017
Masland SR, Price D, MacDonald J, et al: Enduring effects of one-day training in good psychiatric management on clinician attitudes about borderline personality disorder. J Nerv Ment Dis 206(11):865–869, 2018
Masland SR, Victor SE, Peters JR, et al: Destigmatizing borderline personality disorder: a call to action for psychological science. Perspect Psychol Sci 18(2):445–460, 2023
Masood M: Intentional foreign body ingestions: a complex, recurrent and costly issue. Am J Case Rep 22:e934164, 2021
Mavranezouli I, Megnin-Viggars O, Daly C, et al: Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol Med 50(4):542–555, 2020
May T, Pilkington PD, Younan R, et al: Overlap of autism spectrum disorder and borderline personality disorder: a systematic review and meta-analysis. Autism Res 14(12):2688–2710, 2021
McCauley E, Berk MS, Asarnow JR, et al: Efficacy of dialectical behavior therapy for adolescents at high risk for suicide: a randomized clinical trial. JAMA Psychiatry 75(8):777–785, 2018
McDermid J, Sareen J, El-Gabalawy R, et al: Co-morbidity of bipolar disorder and borderline personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Compr Psychiatry 58:18–28, 2015
McGee MD: Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone. J Clin Psychiatry 58(1):32–33, 1997
McGlashan TH, Grilo CM, Skodol AE, et al: The Collaborative Longitudinal Personality Disorders Study: baseline Axis I/II and II/II diagnostic co-occurrence. Acta Psychiatr Scand 102(4):256–264, 2000
McGonigal PT, Dixon-Gordon KL: Anger and emotion regulation associated with borderline and antisocial personality features within a correctional sample. J Correct Health Care 26(3):215–226, 2020
McGuinness LA, Higgins JPT: Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods 12(1):55–61, 2021
McHugh RK, Whitton SW, Peckham AD, et al: Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry 74(6):595–602, 2013
McHugo GJ, Krassenbaum S, Donley S, et al: The prevalence of traumatic brain injury among people with co-occurring mental health and substance use disorders. J Head Trauma Rehabil 32(3):E65–E74, 2017
McIntyre RS, Rosenblat JD, Nemeroff CB, et al: Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry 178(5):383–399, 2021
McKenzie K, Gregory J, Hogg L: Mental health workers’ attitudes towards individuals with a diagnosis of borderline personality disorder: a systematic literature review. J Pers Disord 36(1):70–98, 2022
McMain SF, Links PS, Gnam WH, et al: A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry 166(12):1365–1374, 2009
McMain SF, Guimond T, Streiner DL, et al: Dialectical behavior therapy compared with general psychiatric management for borderline personality disorder: clinical outcomes and functioning over a 2-year follow-up. Am J Psychiatry 169(6):650–661, 2012
McMain SF, Guimond T, Barnhart R, et al: A randomized trial of brief dialectical behaviour therapy skills training in suicidal patients suffering from borderline disorder. Acta Psychiatr Scand 135(2):138–148, 2017
Menschner C, Maul A: Key ingredients for successful trauma-informed care implementation. Advancing Trauma-Informed Care, April 2016. Available at: https://www.samhsa.gov/sites/default/files/programs_campaigns/childrens_mental_health/atc-whitepaper-040616.pdf. Accessed August 27, 2023.
Mental Health America: Mental Health America (website). 2023. Available at: https://www.mhanational.org. Accessed May 6, 2023.
Milinkovic MS, Tiliopoulos N: A systematic review of the clinical utility of the DSM-5 section III alternative model of personality disorder. Personal Disord 11(6):377–397, 2020
Miller AE, Trolio V, Halicki-Asakawa A, et al: Eating disorders and the nine symptoms of borderline personality disorder: a systematic review and series of meta-analyses. Int J Eat Disord 55(8):993–1011, 2022
Miller CE, Townsend ML, Grenyer BFS: Understanding chronic feelings of emptiness in borderline personality disorder: a qualitative study. Borderline Personal Disord Emot Dysregul 8(1):24, 2021
Mintz AR, Dobson KS, Romney DM: Insight in schizophrenia: a meta-analysis. Schizophr Res 61(1):75–88, 2003
Mir J, Kastner S, Priebe S, et al: Treating substance abuse is not enough: comorbidities in consecutively admitted female prisoners. Addict Behav 46:25–30, 2015
Mirbahaeddin E, Chreim S: A narrative review of factors influencing peer support role implementation in mental health systems: implications for research, policy and practice. Adm Policy Ment Health 49(4):596–612, 2022
Moen R, Freitag M, Miller M, et al: Efficacy of extended-release divalproex combined with “condensed” dialectical behavior therapy for individuals with borderline personality disorder. Ann Clin Psychiatry 24(4):255–260, 2012
Mohamed S, Rosenheck R, McEvoy J, et al: Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophr Bull 35(2):336–346, 2009
Moher D, Shamseer L, Clarke M, et al: Preferred Reporting Items for Systematic Review and Meta-Analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4(1):1, 2015
Momen NC, Plana-Ripoll O, Yilmaz Z, et al: Comorbidity between eating disorders and psychiatric disorders. Int J Eat Disord 55(4):505–517, 2022
Morosini PL, Magliano L, Brambilla L, et al: Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 101(4):323–329, 2000
Morton J, Snowdon S, Gopold M, et al: Acceptance and commitment therapy group treatment for symptoms of borderline personality disorder: a public sector pilot study. Cogn Behav Pract 19:527–544, 2012
Moscicki EK, Clarke DE, Kuramoto SJ, et al: Testing DSM-5 in routine clinical practice settings: feasibility and clinical utility. Psychiatr Serv 64(10):952–960, 2013
Murphy CE 4th, Wang RC, Montoy JC, et al: Effect of extended-release naltrexone on alcohol consumption: a systematic review and meta-analysis. Addiction 117(2):271–281, 2022
Murray H, Wortzel HS: Psychiatric advance directives: origins, benefits, challenges, and future directions. J Psychiatr Pract 25(4):303–307, 2019
Nadort M, Arntz A, Smit JH, et al: Implementation of outpatient schema therapy for borderline personality disorder with versus without crisis support by the therapist outside office hours: a randomized trial. Behav Res Ther 47(11):961–973, 2009
Nakic M, Stefanovics EA, Rhee TG, Rosenheck RA: Lifetime risk and correlates of incarceration in a nationally representative sample of U.S. adults with non-substance-related mental illness. Soc Psychiatry Psychiatr Epidemiol 57(9):1839–1847, 2022
Narrow WE, Clarke DE, Kuramoto SJ, et al: DSM-5 field trials in the United States and Canada, part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. Am J Psychiatry 170(1):71–82, 2013
National Alliance on Mental Illness: NAMI Family and Friends. Arlington, VA, National Alliance on Mental Illness, 2023. Available at: https://www.nami.org/find-support/nami-programs/nami-family-friends. Accessed May 6, 2023.
National Commission on Correctional Health Care: Position statement: solitary confinement (isolation). J Correct Health Care 22(3):257–263, 2016
National Council for Mental Wellbeing: Fostering Resilience and Recovery: A Change Package. Washington, DC, National Council for Mental Wellbeing, 2019. Available from: https://www.thenationalcouncil.org/resources/fostering-resilience-and-recovery. Accessed August 27, 2023.
National Education Alliance for Borderline Personality Disorder: Books and Publications. Washington, NJ, National Education Alliance for Borderline Personality Disorder, 2023a. Available at: https://www.borderlinepersonalitydisorder.org/books-publications-2. Accessed May 8, 2023.
National Education Alliance for Borderline Personality Disorder: Family Connections Program. Washington, NJ, National Education Alliance for Borderline Personality Disorder, 2023b. Available at: https://www.borderlinepersonalitydisorder.org/family-connections-programs. Accessed May 6, 2023.
National Education Alliance for Borderline Personality Disorder: National Education Alliance for Borderline Personality Disorder (website). Washington, NJ, National Education Alliance for Borderline Personality Disorder, 2023c. Available at: https://www.borderlinepersonalitydisorder.org. Accessed May 6, 2023.
National Health and Medical Research Council: Clinical Practice Guideline for the Management of Borderline Personality Disorder. Melbourne, Australia, National Health and Medical Research Council, 2012. Available at: https://bpdfoundation.org.au/images/mh25_borderline_personality_guideline.pdf. Accessed April 28, 2023.
National Institute for Health and Care Excellence: Borderline Personality Disorder: Recognition and Management. London, National Institute for Health and Care Excellence, 2009. Available at: https://www.nice.org.uk/guidance/cg78/resources/borderline-personality-disorder-recognition-and-management-pdf-975635141317. Accessed April 28, 2023.
National Institute of Mental Health: Borderline personality disorder, in Mental Health Information: Health Topics. Bethesda, MD, National Institute of Mental Health, 2023. Available at: https://www.nimh.nih.gov/health/topics/borderline-personality-disorder. Accessed April 26, 2023.
Navarro-Haro MV, Botella C, Guillen V, et al: Dialectical behavior therapy in the treatment of borderline personality disorder and eating disorders comorbidity: a pilot study in a naturalistic setting. Cognit Ther Res 42:636–649, 2018
Navarro-Haro MV, Botella VG, Badenes-Ribera L, et al: Dialectical behavior therapy in the treatment of comorbid borderline personality disorder and eating disorder in a naturalistic setting: a six-year follow-up study. Cognit Ther Res 45:480–493, 2021
Neukel C, Bullenkamp R, Moessner M, et al: Anger instability and aggression in borderline personality disorder: an ecological momentary assessment study. Borderline Personal Disord Emot Dysregul 9(1):29, 2022
Neumann A, van Lier PA, Gratz KL, et al: Multidimensional assessment of emotion regulation difficulties in adolescents using the Difficulties in Emotion Regulation Scale. Assessment 17(1):138–149, 2010
New York Presbyterian Hospital: Borderline Personality Disorder Resource Center. New York, New York Presbyterian Hospital, 2023. Available at: https://www.nyp.org/bpdresourcecenter. Accessed August 30, 2023.
Ng FY, Bourke ME, Grenyer BF: Recovery from borderline personality disorder: a systematic review of the perspectives of consumers, clinicians, family and carers. PLoS One 11(8):e0160515, 2016
Ng FYY, Carter PE, Bourke ME, et al: What do individuals with borderline personality disorder want from treatment? A study of self-generated treatment and recovery goals. J Psychiatr Pract 25(2):148–155, 2019a
Ng FYY, Townsend ML, Miller CE, et al: The lived experience of recovery in borderline personality disorder: a qualitative study. Borderline Personal Disord Emot Dysregul 6:10, 2019b
Nickel MK, Nickel C, Mitterlehner FO, et al: Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study. J Clin Psychiatry 65(11):1515–1519, 2004
Nickel MK, Nickel C, Kaplan P, et al: Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biol Psychiatry 57(5):495–499, 2005
Nickel MK, Muehlbacher M, Nickel C, et al: Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Am J Psychiatry 163(5):833–838, 2006
Nickel MK, Loew TH, Pedrosa Gil F: Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up. Psychopharmacology (Berl) 191(4):1023–1026, 2007
Niemantsverdriet MBA, Slotema CW, Blom JD, et al: Hallucinations in borderline personality disorder: prevalence, characteristics and associations with comorbid symptoms and disorders. Sci Rep 7(1):13920, 2017
Niesten IJ, Karan E, Frankenburg FR, et al: Description and prediction of the income status of borderline patients over 10 years of prospective follow-up. Personal Ment Health 10(4):285–292, 2016
Nieuwlaat R, Wilczynski N, Navarro T, et al: Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2014(11):CD000011, 2014
Nuij C, van Ballegooijen W, de Beurs D, et al: Safety planning-type interventions for suicide prevention: meta-analysis. Br J Psychiatry 219(2):419–426, 2021
Office for Civil Rights: HIPAA Privacy Rule and Sharing Information Related to Mental Health. Washington, DC, U.S. Department of Health and Human Services. December 19, 2017. Available at: https://www.hhs.gov/sites/default/files/hipaa-privacy-rule-and-sharing-info-related-to-mental-health.pdf. Accessed November 18, 2018.
Office of the National Coordinator for Health Information Technology: 21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program. Washington, DC, Office of the National Coordinator for Health Information Technology, 2020. Available at: https://www.healthit.gov/cerus/sites/cerus/files/2020–03/ONC_Cures_Act_Final_Rule_.pdf. Accessed February 1, 2023.
Olbert CM, Nagendra A, Buck B: Meta-analysis of Black vs. White racial disparity in schizophrenia diagnosis in the United States: do structured assessments attenuate racial disparities? J Abnorm Psychol 127(1):104–115, 2018
Oldham JM: Guideline Watch: Practice Guideline for the Treatment of Patients With Borderline Personality Disorder. Washington, DC, American Psychiatric Association, 2005. Available at: https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/bpd-watch-1410457064610.pdf. Accessed November 29, 2022.
Oldham JM: Borderline personality disorder and suicidality. Am J Psychiatry 163(1):20–26, 2006
Oldham JM: How will clinicians utilize the alternative DSM-5-TR Section III Model for Personality Disorders in their clinical work? Ask the Expert Column. Focus Am Psychiatr Publ 20(4):411–412, 2022a
Oldham JM: The therapeutic alliance. J Psychiatr Pract 28(5):353, 2022b
Oldham JM, Morris LB: The New Personality Self-Portrait: Why You Think, Work, Love, and Act the Way You Do. New York, Bantum Books, 1995
Palmier-Claus JE, Ainsworth J, Machin M, et al: The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application. BMC Psychiatry 12:172, 2012
Paris J: Why patients with severe personality disorders are overmedicated. J Clin Psychiatry 76(4):e521, 2015
Paris J: Suicidality in borderline personality disorder. Medicina (Kaunas) 55(6):223, 2019
Parsons B, Quitkin FM, McGrath PJ, et al: Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression. Psychopharmacol Bull 25(4):524–534, 1989
Pascual JC, Soler J, Puigdemont D, et al: Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. J Clin Psychiatry 69(4):603–608, 2008
Pascual JC, Palomares N, Ibáñez Á, et al: Efficacy of cognitive rehabilitation on psychosocial functioning in borderline personality disorder: a randomized controlled trial. BMC Psychiatry 15:255, 2015
Pascual JC, Arias L, Soler J: Pharmacological management of borderline personality disorder and common comorbidities. CNS Drugs 37(6):489–497, 2023
Patel MM, Brown JD, Croake S, et al: The current state of behavioral health quality measures: where are the gaps? Psychiatr Serv 66(8):865–871, 2015
Peh KQE, Kwan YH, Goh H, et al: An adaptable framework for factors contributing to medication adherence: results from a systematic review of 102 conceptual frameworks. J Gen Intern Med 36(9):2784–2795, 2021
Penner F, Steinberg L, Sharp C: The development and validation of the Difficulties in Emotion Regulation Scale–8: providing respondents with a uniform context that elicits thinking about situations requiring emotion regulation. J Pers Assess 28:1–10, 2022
Pfohl B, Blum N, St John D, et al: Reliability and validity of the Borderline Evaluation of Severity Over Time (BEST): a self-rated scale to measure severity and change in persons with borderline personality disorder. J Pers Disord 23(3):281–293, 2009
Philips B, Wennberg P, Konradsson P, et al: Mentalization-based treatment for concurrent borderline personality disorder and substance use disorder: a randomized controlled feasibility study. Eur Addict Res 24(1):1–8, 2018
Philipsen A, Limberger MF, Lieb K, et al: Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry 192(2):118–123, 2008
Pincus HA, Scholle SH, Spaeth-Rublee B, et al: Quality measures for mental health and substance use: gaps, opportunities, and challenges. Health Aff (Millwood) 35(6):1000–1008, 2016
Porter C, Palmier-Claus J, Branitsky A, et al: Childhood adversity and borderline personality disorder: a meta-analysis. Acta Psychiatr Scand 141(1):6–20, 2020
Prevolnik Rupel V, Jagger B, Fialho LS, et al: Standard set of patient-reported outcomes for personality disorder. Qual Life Res 30(12):3485–3500, 2021
Proctor JM, Lawn S, McMahon J: Consumer perspective from people with a diagnosis of borderline personality disorder (BPD) on BPD management-How are the Australian NHMRC BPD guidelines faring in practice? J Psychiatr Ment Health Nurs 28(4):670–681, 2021
Qadeer Shah A, Prasad D, Caropreso L, et al: The comorbidity between borderline personality disorder (BPD) and generalized anxiety disorder (GAD): a systematic review and meta-analysis. J Psychiatr Res 164:304–314, 2023
Qian X, Townsend ML, Tan WJ, et al: Sex differences in borderline personality disorder: a scoping review. PLoS One 17(12):e0279015, 2022
Rada RT, James W: Urethral insertion of foreign bodies: a report of contagious self-mutilation in a maximum-security hospital. Arch Gen Psychiatry 39(4):423–429, 1982
Raja S, Hasnain M, Hoersch M, et al: Trauma informed care in medicine: current knowledge and future research directions. Fam Community Health 38(3):216–226, 2015
Rasmussen KG: Do patients with personality disorders respond differentially to electroconvulsive therapy? A review of the literature and consideration of conceptual issues. J ECT 31(1):6–12, 2015
Reas DL, Rø Ø, Karterud S, et al: Eating disorders in a large clinical sample of men and women with personality disorders. Int J Eat Disord 46(8):801–809, 2013
Reich DB, Zanarini MC, Bieri KA: A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder. Int Clin Psychopharmacol 24(5):270–275, 2009
Reingle Gonzalez JM, Connell NM: Mental health of prisoners: identifying barriers to mental health treatment and medication continuity. Am J Public Health 104(12):2328–2333, 2014
Reisner AD, Bornovalova MA, Gordish L, et al: Ingestion of foreign objects as a means of nonlethal self-injury. Personal Disord 4(2):182–189, 2013
Reneses B, Galián M, Serrano R, et al: A new time limited psychotherapy for BPD: preliminary results of a randomized and controlled trial. Actas Esp Psiquiatr 41(3):139–148, 2013
Reyes-López J, Ricardo-Garcell J, Armas-Castañeda G, et al: Clinical improvement in patients with borderline personality disorder after treatment with repetitive transcranial magnetic stimulation: preliminary results. Br J Psychiatry 40(1):97–104, 2018
Rhee TG, Shim SR, Forester BP, et al: Efficacy and safety of ketamine vs electroconvulsive therapy among patients with major depressive episode: a systematic review and meta-analysis. JAMA Psychiatry 79(12):1162–1172, 2022
Ripoll LH: Psychopharmacologic treatment of borderline personality disorder. Dialogues Clin Neurosci 15(2):213–224, 2013
Ritschel LA, Tone EB, Schoemann AM, et al: Psychometric properties of the Difficulties in Emotion Regulation Scale across demographic groups. Psychol Assess 27(3):944–954, 2015
Robinson P, Hellier J, Barrett B, et al: The NOURISHED randomised controlled trial comparing mentalisation-based treatment for eating disorders (MBT-ED) with specialist supportive clinical management (SSCM-ED) for patients with eating disorders and symptoms of borderline personality disorder. Trials 17(1):549, 2016
Rodriguez-Seijas C, Morgan TA, Zimmerman M: Is there a bias in the diagnosis of borderline personality disorder among lesbian, gay, and bisexual patients? Assessment 28(3):724–738, 2021
Rodriguez-Seijas C, Rogers BG, Asadi S: Personality disorders research and social decontextualization: what it means to be a minoritized human. Personal Disord 14(1):29–38, 2023
Rohde C, Polcwiartek C, Correll CU, Nielsen J: Real-world effectiveness of clozapine for borderline personality disorder: results from a 2-year mirror-image study. J Pers Disord 32(6):823–837, 2018
Romanowicz M, Schak KM, Vande Voort JL, et al: Prescribing practices for patients with borderline personality disorder during psychiatric hospitalizations. J Pers Disord 34(6):736–749, 2020
Roth AS, Ostroff RB, Hoffman RE: Naltrexone as a treatment for repetitive self-injurious behaviour: an open-label trial. J Clin Psychiatry 57(6):233–237, 1996
Rudge S, Feigenbaum JD, Fonagy P: Mechanisms of change in dialectical behaviour therapy and cognitive behaviour therapy for borderline personality disorder: a critical review of the literature. J Ment Health 29(1):92–102, 2020
Rudolph K: Ethical considerations in trauma-informed care. Psychiatr Clin North Am 44(4):521–535, 2021
Sachdeva S, Goldman G, Mustata G, et al: Naturalistic outcomes of evidence-based therapies for borderline personality disorder at a university clinic: a quasi-randomized trial. J Am Psychoanal Assoc 61(3):578–584, 2013
Sachs HC, Committee On Drugs: The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics 132(3):e796–e809, 2013
Saks ER: Some thoughts on denial of mental illness. Am J Psychiatry 166(9):972–973, 2009
Sansone RA, Sansone LA: Measuring self-harm behavior with the self-harm inventory. Psychiatry (Edgmont) 7(4):16–20, 2010
Sansone RA, Sansone LA: Chronic pain syndromes and borderline personality. Innov Clin Neurosci 9(1):10–14, 2012
Sansone RA, Levitt JL, Sansone LA: The prevalence of personality disorders among those with eating disorders. Eat Disord 13(1):7–21, 2005
Santisteban DA, Mena MP, Muir J, et al: The efficacy of two adolescent substance abuse treatments and the impact of comorbid depression: results of a small randomized controlled trial. Psychiatr Rehabil J 38(1):55–64, 2015
Santo T Jr, Campbell G, Gisev N, et al: Prevalence of mental disorders among people with opioid use disorder: a systematic review and meta-analysis. Drug Alcohol Depend 238:109551, 2022
Saunders KRK, McGuinness E, Barnett P, et al: A scoping review of trauma informed approaches in acute, crisis, emergency, and residential mental health care. BMC Psychiatry 23(1):567, 2023
Scalabrini A, Cavicchioli M, Fossati A, et al: The extent of dissociation in borderline personality disorder: a meta-analytic review. J Trauma Dissociation 18(4):522–543, 2017
Schechter M, Ronningstam E, Herbstman B, et al: Psychotherapy with suicidal patients: the integrative psychodynamic approach of the Boston Suicide Study Group. Medicina (Kaunas) 55(6):303, 2019
Scheiderer EM, Wood PK, Trull TJ: The comorbidity of borderline personality disorder and posttraumatic stress disorder: revisiting the prevalence and associations in a general population sample. Borderline Personal Disord Emot Dysregul 2:11, 2015
Schmidt C, Soler J, Carmona I Farrés C, et al: Mindfulness in borderline personality disorder: decentering mediates the effectiveness. Psicothema 33(3):407–414, 2021
Schneider F, Erhart M, Hewer W, et al: Mortality and medical comorbidity in the severely mentally ill. Dtsch Arztebl Int 116(23–24):405–411, 2019
Schulz SC, Zanarini MC, Bateman A, et al: Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. Br J Psychiatry 193(6):485–492, 2008
Schwartz RC, Blankenship DM: Racial disparities in psychotic disorder diagnosis: a review of empirical literature. World J Psychiatry 4(4):133–140, 2014
Sederer LI, Ellison J, Keyes C: Guidelines for prescribing psychiatrists in consultative, collaborative, and supervisory relationships. Psychiatr Serv 49(9):1197–1202, 1998
Seid AK, Hesse M, Houborg E, et al: Substance use and violent victimization: evidence from a cohort of >82,000 patients treated for alcohol and drug use disorder in Denmark. J Interpers Violence 37(13–14):NP12427–NP12452, 2022
Semenza DC, Grosholz JM: Mental and physical health in prison: how co-occurring conditions influence inmate misconduct. Health Justice 7(1):1, 2019
Shah R, Temes CM, Frankenburg FR, et al: Levels of depersonalization and derealization reported by recovered and non-recovered borderline patients over 20 years of prospective follow-up. J Trauma Dissociation 21(3):337–348, 2020
Shapiro-Thompson R, Fineberg SK: The state of overmedication in borderline personality disorder: interpersonal and structural factors. Curr Treat Options Psychiatry 9(1):1–13, 2022
Sharp C: Bridging the gap: the assessment and treatment of adolescent personality disorder in routine clinical care. Arch Dis Child 102(1):103–108, 2017
Sharp C, Fonagy P: Practitioner review: borderline personality disorder in adolescence: recent conceptualization, intervention, and implications for clinical practice. J Child Psychol Psychiatry 56(12):1266–1288, 2015
Sharp C, Wall K: Personality pathology grows up: adolescence as a sensitive period. Curr Opin Psychol 21:111–116, 2018
Sharp C, Wall K: DSM-5 level of personality functioning: refocusing personality disorder on what it means to be human. Annu Rev Clin Psychol 17:313–337, 2021
Sharp C, Mosko O, Chang B, et al: The cross-informant concordance and concurrent validity of the Borderline Personality Features Scale for Children in a community sample of boys. Clin Child Psychol Psychiatry 16(3):335–349, 2011
Sharp C, Steinberg L, Temple J, et al: An 11-item measure to assess borderline traits in adolescents: refinement of the BPFSC using IRT. Personal Disord 5(1):70–78, 2014
Sharp C, Kerr S, Barkauskiene R: The incremental utility of maladaptive self and identity functioning over general functioning for borderline personality disorder features in adolescents. Personal Disord 13(5):474–481, 2022
Sheehan L, Nieweglowski K, Corrigan P: The stigma of personality disorders. Curr Psychiatry Rep 18(1):11, 2016
Shields LS, Pathare S, van der Ham AJ, et al: A review of barriers to using psychiatric advance directives in clinical practice. Adm Policy Ment Health 41(6):753–766, 2014
Silverman MH, Frankenburg FR, Reich DB, et al: The course of anxiety disorders other than PTSD in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. J Pers Disord 26(5):804–814, 2012
Simonsen S, Bateman A, Bohus M, et al: European guidelines for personality disorders: past, present and future. Borderline Personal Disord Emot Dysregul 6:9, 2019
Simpson EB, Yen S, Costello E, et al: Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. J Clin Psychiatry 65(3):379–385, 2004
Sims E, Nelson KJ, Sisti D: Borderline personality disorder, therapeutic privilege, integrated care: is it ethical to withhold a psychiatric diagnosis? J Med Ethics 48(11):801–804, 2022
Sinnaeve R, van den Bosch LMC, Hakkaart-van Roijen L, et al: Effectiveness of step-down versus outpatient dialectical behaviour therapy for patients with severe levels of borderline personality disorder: a pragmatic randomized controlled trial. Borderline Personal Disord Emot Dysregul 5:12, 2018
Sisti D, Segal AG, Siegel AM, et al: Diagnosing, disclosing, and documenting borderline personality disorder: a survey of psychiatrists’ practices. J Pers Disord 30(6):848–856, 2016
Skevington SM, Lotfy M, O’Connell KA, et al: The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 13(2):299–310, 2004
Skodol AE, Oldham JM (eds): The American Psychiatric Association Publishing Textbook of Personality Disorders, 3rd Edition. Washington, DC, American Psychiatric Association Publishing, 2021
Skodol AE, Oldham JM, Hyler SE, et al: Comorbidity of DSM-III-R eating disorders and personality disorders. Int J Eat Disord 14(4):403–416, 1993
Skodol AE, Grilo CM, Keyes KM, et al: Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am J Psychiatry 168(3):257–264, 2011
Skutch JM, Wang SB, Buqo T, et al: Which brief is best? Clarifying the use of three brief versions of the Difficulties in Emotion Regulation Scale. J Psychopathol Behav Assess 41(3):485–494, 2019
Sledge W, Plakun EM, Bauer S, et al: Psychotherapy for suicidal patients with borderline personality disorder: an expert consensus review of common factors across five therapies. Borderline Personal Disord Emot Dysregul 1:16, 2014
Slotema CW, Blom JD, Niemantsverdriet MBA, et al: Auditory verbal hallucinations in borderline personality disorder and the efficacy of antipsychotics: a systematic review. Front Psychiatry 9:347, 2018
Slotema CW, Wilhelmus B, Arends LR, et al: Psychotherapy for posttraumatic stress disorder in patients with borderline personality disorder: a systematic review and meta-analysis of its efficacy and safety. Eur J Psychotraumatol 11(1):1796188, 2020
Smith FA, Levenson JL, Stern TA: Psychiatric assessment and consultation, in The American Psychiatric Association Publishing Textbook of Psychosomatic Medicine and Consultation-Liaison Psychiatry, 3rd Edition. Edited by Levenson JL. Washington, DC, American Psychiatric Association Publishing, 2019
Smits ML, Feenstra DJ, Eeren HV, et al: Day hospital versus intensive out-patient mentalisation-based treatment for borderline personality disorder: multicentre randomised clinical trial. Br J Psychiatry 216(2):79–84, 2020
Smits ML, Feenstra DJ, Bales DL, et al: Day hospital versus intensive outpatient mentalization-based treatment: 3-year follow-up of patients treated for borderline personality disorder in a multicentre randomized clinical trial. Psychol Med 52(3):485–495, 2022
Söderholm JJ, Socada JL, Rosenström T, et al: Borderline personality disorder with depression confers significant risk of suicidal behavior in mood disorder patients-a comparative study. Front Psychiatry 11:290, 2020
Soler J, Pascual JC, Campins J, et al: Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. Am J Psychiatry 162(6):1221–1224, 2005
Soler J, Pascual JC, Tiana T, et al: Dialectical behaviour therapy skills training compared to standard group therapy in borderline personality disorder: a 3-month randomised controlled clinical trial. Behav Res Ther 47(5):353–358, 2009
Soler J, Casellas-Pujol E, Fernández-Felipe I, et al: “Skills for pills”: the dialectical-behavioural therapy skills training reduces polypharmacy in borderline personality disorder. Acta Psychiatr Scand 145(4):332–342, 2022
Solmi M, Dragioti E, Croatto G, et al: Risk and protective factors for personality disorders: an umbrella review of published meta-analyses of case-control and cohort studies. Front Psychiatry 12:679379, 2021
Soloff PH: Bridging the gap between remission and recovery in BPD: qualitative versus quantitative perspectives. J Pers Disord 35(1):21–40, 2021
Sommer JL, Blaney C, Mota N, et al: Dissociation as a transdiagnostic indicator of self-injurious behavior and suicide attempts: a focus on posttraumatic stress disorder and borderline personality disorder. J Trauma Stress 34(6):1149–1158, 2021
Soulier MF, Maislen A, Beck JC: Status of the psychiatric duty to protect, circa 2006. J Am Acad Psychiatry Law 38(4):457–473, 2010
Spengler ES, Miller DJ, Spengler PM: Microaggressions: clinical errors with sexual minority clients. Psychotherapy (Chic) 53(3):360–366, 2016
Spinhoven P, Giesen-Bloo J, van Dyck R, et al: The therapeutic alliance in schema-focused therapy and transference-focused psychotherapy for borderline personality disorder. J Consult Clin Psychol 75(1):104–115, 2007
Stanley B, Brown GK: Safety planning intervention: a brief intervention to mitigate suicide risk. Cogn Behav Pract 19(2):256–264, 2012
Stanley B, Brown GK, Brenner LA, et al: Comparison of the safety planning intervention with follow-up vs usual care of suicidal patients treated in the emergency department. JAMA Psychiatry 75(9):894–900, 2018
Stapleton A, Wright N: The experiences of people with borderline personality disorder admitted to acute psychiatric inpatient wards: a meta-synthesis. J Ment Health 28(4):443–457, 2019
Starcevic V, Janca A: Pharmacotherapy of borderline personality disorder: replacing confusion with prudent pragmatism. Curr Opin Psychiatry 31(1):69–73, 2018
Steadman HJ, Osher FC, Robbins PC, et al: Prevalence of serious mental illness among jail inmates. Psychiatr Serv 60(6):761–765, 2009
STEPPS: Systems Training for Emotional Predictability and Problem Solving. Level 1 Publishing, 2022. Available at: https://www.steppsforbpd.com. Accessed March 2, 2023.
Sterne JA, Hernán MA, Reeves BC, et al: ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919, 2016
Sterne JAC, Savovic J, Page MJ, et al: RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898, 2019
Stiles C, Batchelor R, Gumley A, et al: Experiences of stigma and discrimination in borderline personality disorder: a systematic review and qualitative meta-synthesis. J Pers Disord 37(2):177–194, 2023
Stoffers-Winterling JM, Storebø OJ, Pereira Ribeiro J, et al: Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev 11(11):CD012956, 2022
Stone MH: Borderline patients: 25 to 50 years later: with commentary on outcome factors. Psychodyn Psychiatry 45(2):259–296, 2017
Storebø OJ, Stoffers-Winterling JM, Völlm BA, et al: Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 5(5):CD012955, 2020
Strub RL, Black FW: The Mental Status Examination in Neurology. Philadelphia, PA, F.A. Davis Co., 2000
Stubbe DE: The therapeutic alliance: the fundamental element of psychotherapy. Focus Am Psychiatr Publ 16(4):402–403, 2018
Substance Abuse and Mental Health Services Administration: SAFE-T Pocket Card: Suicide and Five-Step Evaluation and Triage. Rockville, MD, Substance Abuse and Mental Health Services Administration, September 2009. Available at: https://store.samhsa.gov/product/SAFE-T-Pocket-Card-Suicide-Assessment-Five-Step-Evaluation-and-Triage-for-Clinicians/sma09-4432. Accessed April 26, 2023.
Substance Abuse and Mental Health Services Administration: SAMHSA’s Working Definition of Recovery: 10 Guiding Principles of Recovery. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2012. Available at: https://store.samhsa.gov/sites/default/files/pep12-recdef.pdf. Accessed August 3, 2019.
Substance Abuse and Mental Health Services Administration: SAMHSA’s Concept of Trauma and Guidance for a Trauma-Informed Approach. HHS Publ No (SMA) 14-4884. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2014. Available at: https://ncsacw.acf.hhs.gov/userfiles/files/SAMHSA_Trauma.pdf. Accessed August 27, 2023.
Substance Abuse and Mental Health Services Administration: Peer support workers for those in recovery, in Recovery Support Tools and Resources. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2022. Available at: https://www.samhsa.gov/brss-tacs/recovery-support-tools/peers. Accessed September 2, 2023.
Sue DW, Capodilupo CM, Torino GC, et al: Racial microaggressions in everyday life: implications for clinical practice. Am Psychol 62(4):271–286, 2007
Sulzer SH, Muenchow E, Potvin A, et al: Improving patient-centered communication of the borderline personality disorder diagnosis. J Ment Health 25(1):5–9, 2016
Tamburello A, Metzner J, Fergusen E, et al: The American Academy of Psychiatry and the Law practice resource for prescribing in corrections. J Am Acad Psychiatry Law 46(2):242–243, 2018
Tate AE, Sahlin H, Liu S, et al: Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors. Mol Psychiatry 27(5):2514–2521, 2022
Temes CM, Frankenburg FR, Fitzmaurice GM, et al: Deaths by suicide and other causes among patients with borderline personality disorder and personality-disordered comparison subjects over 24 years of prospective follow-up. J Clin Psychiatry 80(1):18m12436, 2019
The Joint Commission: National Patient Safety Goals® Effective January 2023 for the Hospital Program. Oakbrook Terrace, IL, The Joint Commission, 2022. Available at: https://www.jointcommission.org/-/media/tjc/documents/standards/national-patient-safety-goals/2023/npsg_chapter_hap_jan2023.pdf. Accessed April 4, 2023.
Timäus C, Meiser M, Wiltfang J, et al: Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients. Hum Psychopharmacol 36(6):e2800, 2021
Tomko RL, Trull TJ, Wood PK, et al: Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Pers Disord 28(5):734–750, 2014
Tong P, Bo P, Shi Y, et al: Clinical traits of patients with major depressive disorder with comorbid borderline personality disorder based on propensity score matching. Depress Anxiety 38(1):100–106, 2021
Torgersen J: Textbook of Personality Disorders. Washington, DC, American Psychiatric Publishing, 2005
Tosato S, Albert U, Tomassi S, et al: A systematized review of atypical antipsychotics in pregnant women: balancing between risks of untreated illness and risks of drug-related adverse effects. J Clin Psychiatry 78(5):e477–e489, 2017
Tritt K, Nickel C, Lahmann C, et al: Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. J Psychopharmacol 19(3):287–291, 2005
Trull TJ, Jahng S, Tomko RL, et al: Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord 24(4):412–426, 2010
Trull TJ, Freeman LK, Vebares TJ, et al: Borderline personality disorder and substance use disorders: an updated review. Borderline Personal Disord Emot Dysregul 5:15, 2018
Tyrer P, Tom B, Byford S, et al: Differential effects of manual assisted cognitive behavior therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. J Pers Disord 18(1):102–116, 2004
U.S. Food and Drug Administration: Drug safety communication: antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns. U.S. Food and Drug Administration, February 22, 2011. Available at: https://www.fda.gov/Drugs/DrugSafety/ucm243903.htm#sa. Accessed September 22, 2019.
Üstün TB, Kostanjsek N, Chatterji S, et al: Measuring Health and Disability: Manual for the WHO Disability Assessment Schedule (WHODAS 2.0). Geneva, World Health Organization, 2010
Valenstein M, Adler DA, Berlant J, et al: Implementing standardized assessments in clinical care: now’s the time. Psychiatr Serv 60(10):1372–1375, 2009
van den Bosch LM, Koeter MW, Stijnen T, et al: Sustained efficacy of dialectical behaviour therapy for borderline personality disorder. Behav Res Ther 43(9):1231–1241, 2005
Van den Eynde V, Abdelmoemin WR, Abraham MM, et al: The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. CNS Spectr 15:1–14, 2022a
Van den Eynde V, Gillman PK, Blackwell BB: The prescriber’s guide to the MAOI diet: thinking through tyramine troubles. Psychopharmacol Bull 52(2):73–116, 2022b
Vanek J, Prasko J, Ociskova M, et al: Insomnia in patients with borderline personality disorder. Nat Sci Sleep 13:239–250, 2021
Vanicek T, Unterholzner J, Lanzenberger R, et al: Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder. World J Biol Psychiatry 23(9):715–718, 2022
Vanwoerden S, Garey L, Ferguson T, et al: Borderline Personality Features Scale for Children-11: measurement invariance over time and across gender in a community sample of adolescents. Psychol Assess 31(1):114–119, 2019
Verheul R, Van Den Bosch LM, Koeter MW, et al: Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. Br J Psychiatry 182:135–140, 2003
Victor G, Hedden-Clayton B: Substance use and violence victimization among women: a review of relevant literature. Violence Vict 38(1):25–52, 2023
Victor SE, Klonsky ED: Validation of a brief version of the Difficulties in Emotion Regulation Scale (DERS-18) in five samples. J Psychopathol Behav Assess 38(4):582–589, 2016
Videler AC, Hutsebaut J, Schulkens JEM, et al: A life span perspective on borderline personality disorder. Curr Psychiatry Rep 21(7):51, 2019
Volkert J, Gablonski TC, Rabung S: Prevalence of personality disorders in the general adult population in Western countries: systematic review and meta-analysis. Br J Psychiatry 213(6):709–715, 2018
Wall K, Ahmed Y, Sharp C: Parent-adolescent concordance in borderline pathology and why it matters. J Abnorm Child Psychol 47(3):529–542, 2019
Walton CJ, Bendit N, Baker AL, et al: A randomised trial of dialectical behaviour therapy and the conversational model for the treatment of borderline personality disorder with recent suicidal and/or non-suicidal self-injury: an effectiveness study in an Australian public mental health service. Aust N Z J Psychiatry 54(10):1020–1034, 2020
Wang K, Varma DS, Prosperi M: A systematic review of the effectiveness of mobile apps for monitoring and management of mental health symptoms or disorders. J Psychiatr Res 107:73–78, 2018
Ward HB, Yip A, Siddiqui R, et al: Borderline personality traits do not influence response to TMS. J Affect Disord 281:834–838, 2021
Watkins K, Horvitz-Lennon M, Caldarone LB, et al: Developing medical record-based performance indicators to measure the quality of mental healthcare. J Healthc Qual 33(1):49–66, quiz 66–67, 2011
Watkins KE, Farmer CM, De Vries D, et al: The Affordable Care Act: an opportunity for improving care for substance use disorders? Psychiatr Serv 66(3):310–312, 2015
Watkins KE, Smith B, Akincigil A, et al: The quality of medication treatment for mental disorders in the Department of Veterans Affairs and in private-sector plans. Psychiatr Serv 67(4):391–396, 2016
Way BB, Miraglia R, Sawyer DA, et al: Factors related to suicide in New York state prisons. Int J Law Psychiatry 28(3):207–221, 2005
Weekers LC, Hutsebaut J, Kamphuis JH: The Level of Personality Functioning Scale–Brief Form 2.0: update of a brief instrument for assessing level of personality functioning. Personal Ment Health 13(1):3–14, 2019
Weinberg I, Gunderson JG, Hennen J, Cutter CJ Jr: Manual assisted cognitive treatment for deliberate self-harm in borderline personality disorder patients. J Pers Disord 20(5):482–492, 2006
Weiner AS, Ensink K, Normandin L: Psychotherapy for borderline personality disorder in adolescents. Psychiatr Clin North Am 41(4):729–746, 2018
Wenzlow AT, Ireys HT, Mann B, et al: Effects of a discharge planning program on Medicaid coverage of state prisoners with serious mental illness. Psychiatr Serv 62(1):73–78, 2011
Wetterborg D, Långström N, Andersson G, et al: Borderline personality disorder: prevalence and psychiatric comorbidity among male offenders on probation in Sweden. Compr Psychiatry 62:63–70, 2015
WHOQOL Group: Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 28(3):551–558, 1998
Wilder CM, Elbogen EB, Moser LL, et al: Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives. Psychiatr Serv 61(4):380–385, 2010
Wilhelmus B, Marissen MAE, van den Berg D, et al: Adding EMDR for PTSD at the onset of treatment of borderline personality disorder: a pilot study. J Behav Ther Exp Psychiatry 79:101834, 2023
Wilkinson ST, Trujillo Diaz D, Rupp ZW, et al: Pharmacological and somatic treatment effects on suicide in adults: a systematic review and meta-analysis. Focus Am Psychiatr Publ 21(2):197–208, 2023
Williamson D, Turkoz I, Wajs E, et al: Adverse events and measurement of dissociation after the first dose of esketamine in patients with TRD. Int J Neuropsychopharmacol 26(3):198–206, 2023
Wilper AP, Woolhandler S, Boyd JW, et al: The health and health care of US prisoners: results of a nationwide survey. Am J Public Health 99(4):666–672, 2009
Winsper C: Borderline personality disorder: course and outcomes across the lifespan. Curr Opin Psychol 37:94–97, 2021
Winsper C, Tang NK, Marwaha S, et al: The sleep phenotype of borderline personality disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev 73:48–67, 2017
Winsper C, Bilgin A, Thompson A, et al: The prevalence of personality disorders in the community: a global systematic review and meta-analysis. Br J Psychiatry 216(2):69–78, 2020
Woodbridge J, Townsend M, Reis S, et al: Non-response to psychotherapy for borderline personality disorder: a systematic review. Aust N Z J Psychiatry 56(7):771–787, 2022
Woodbridge J, Townsend ML, Reis SL, et al: Patient perspectives on non-response to psychotherapy for borderline personality disorder: a qualitative study. Borderline Personal Disord Emot Dysregul 10(1):13, 2023
World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva, World Health Organization, 1992
Wortzel HS, Simonetti JA, Oslin DW, et al: Lithium use for suicide prevention, revisited. J Psychiatr Pract 29(1):51–57, 2023
Yadav D: Prescribing in borderline personality disorder: the clinical guidelines. Prog Neurol Psychiatry 24(2):25–30, 2020
Yasmeen S, Tangney JP, Stuewig JB, et al: The implications of borderline personality features for jail inmates’ institutional misconduct and treatment-seeking. Personal Disord 13(5):505–515, 2022
Yen S, Peters JR, Nishar S, et al: Association of borderline personality disorder criteria with suicide attempts: findings from the collaborative longitudinal study of personality disorders over 10 years of follow-up. JAMA Psychiatry 78(2):187–194, 2021
Yeomans FE, Clarkin JF, Kernberg OF: Transference-Focused Psychotherapy for BPD: A Clinical Guide. Washington, DC, American Psychiatric Publishing, 2015
Yildiz A, Siafis S, Mavridis D, et al: Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis. Lancet Psychiatry 10(9):693–705, 2023
Young JE, Klosko J, Weishaar ME: Schema Therapy: A Practitioner’s Guide. New York, Guilford, 2003
Young MH, Justice JV, Erdberg P: Risk of harm: inmates who harm themselves while in prison psychiatric treatment. J Forensic Sci 51(1):156–162, 2006
Zanarini MC, Frankenburg FR: Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 62(11):849–854, 2001
Zanarini MC, Frankenburg FR: A preliminary, randomized trial of psychoeducation for women with borderline personality disorder. J Pers Disord 22(3):284–290, 2008
Zanarini MC, Gunderson JG, Frankenburg FR, et al: Discriminating borderline personality disorder from other axis II disorders. Am J Psychiatry 147(2):161–167, 1990
Zanarini MC, Frankenburg FR, Dubo ED, et al: Axis I comorbidity of borderline personality disorder. Am J Psychiatry 155(12):1733–1739, 1998
Zanarini MC, Vujanovic AA, Parachini EA, et al: Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord 17(3):233–242, 2003
Zanarini MC, Frankenburg FR, Hennen J, et al: Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry 161(11):2108–2114, 2004a
Zanarini MC, Frankenburg FR, Hennen J, et al: Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry 65(1):28–36, 2004b
Zanarini MC, Frankenburg FR, Parachini EA: A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry 65(7):903–907, 2004c
Zanarini MC, Frankenburg FR, Reich DB, et al: The 10-year course of physically self-destructive acts reported by borderline patients and Axis II comparison subjects. Acta Psychiatr Scand 117(3):177–184, 2008
Zanarini MC, Reichman CA, Frankenburg FR, et al: The course of eating disorders in patients with borderline personality disorder: a 10-year follow-up study. Int J Eat Disord 43(3):226–232, 2010
Zanarini MC, Horwood J, Wolke D, et al: Prevalence of DSM-IV borderline personality disorder in two community samples: 6,330 English 11-year-olds and 34,653 American adults. J Pers Disord 25(5):607–619, 2011a
Zanarini MC, Schulz SC, Detke HC, et al: A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study. J Clin Psychiatry 72(10):1353–1362, 2011b
Zanarini MC, Frankenburg FR, Reich DB, et al: Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and Axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry 169(5):476–483, 2012
Zanarini MC, Weingeroff JL, Frankenburg FR, et al: Development of the self-report version of the Zanarini Rating Scale for Borderline Personality Disorder. Personal Ment Health 9(4):243–249, 2015
Zanarini MC, Temes CM, Ivey AM, et al: The 10-year course of adult aggression toward others in patients with borderline personality disorder and axis II comparison subjects. Psychiatry Res 252:134–138, 2017
Zanarini MC, Conkey LC, Temes CM, et al: Randomized controlled trial of web-based psychoeducation for women with borderline personality disorder. J Clin Psychiatry 79(3):79, 2018
Zanarini MC, Hörz-Sagstetter S, Temes CM, et al: The 24-year course of major depression in patients with borderline personality disorder and personality-disordered comparison subjects. J Affect Disord 258:109–114, 2019
Zanarini MC, Athanasiadi A, Temes CM, et al: Symptomatic disorders in adults and adolescents with borderline personality disorder. J Pers Disord 35(Suppl B):48–55, 2021
Zeifman RJ, Landy MSH, Liebman RE, et al: Optimizing treatment for comorbid borderline personality disorder and posttraumatic stress disorder: a systematic review of psychotherapeutic approaches and treatment efficacy. Clin Psychol Rev 86:102030, 2021
Zimmerman M, Becker L: The hidden borderline patient: patients with borderline personality disorder who do not engage in recurrent suicidal or self-injurious behavior. Psychol Med 53(11):5177–5184, 2023
Zimmerman M, Mattia JI: Axis I diagnostic comorbidity and borderline personality disorder. Compr Psychiatry 40(4):245–252, 1999
Zimmermann J, Kerber A, Rek K, et al: A brief but comprehensive review of research on the Alternative DSM-5 Model for Personality Disorders. Curr Psychiatry Rep 21(9):92, 2019
Zimmerman M, Chelminski I, Young D, et al: Using outcome measures to promote better outcomes. Clin Neuropsychiatry 8:28–36, 2011
Zimmerman M, Chelminski I, Dalrymple K, et al: Principal diagnoses in psychiatric outpatients with borderline personality disorder: implications for screening recommendations. Ann Clin Psychiatry 29(1):54–60, 2017
Zimmerman M, McGonigal P, Moon SS, et al: Does diagnosing a patient with borderline personality disorder negatively impact patient satisfaction with the initial diagnostic evaluation? Ann Clin Psychiatry 30(3):215–219, 2018
Zimmerman M, Benjamin I, Seijas-Rodriguez C: Psychiatric diagnoses among transgender and gender diverse patients compared to cisgender patients. J Clin Psychiatry 83(6):21m14062, 2022
Information & Authors
Information
Published In
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Borderline Personality Disorder
November 2024
©American Psychiatric Association Publishing
Authors
Metrics & Citations
Metrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
Get Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).